ยาแก้ซึมเศร้า (Thai Wikipedia)

Fournier, JC; DeRubeis, RJ; Hollon, SD; Dimidjian, S; Amsterdam, JD; Shelton, RC; Fawcett, J (Jan 2010). "Antidepressant Drug Effects and Depression Severity". JAMA: The Journal of the American Medical Association. 303 (1): 47–53. doi:10.1001/jama.2009.1943. PMC 3712503. PMID 20051569.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)

apotex.com

"Paroxetine prescribing information" (PDF). Apotex. สืบค้นเมื่อ 2015-01-30.

archive.org

Whittington, CJ; Kendall, T; Fonagy, P; Cottrell, D; Cotgrove, A; Boddington, E (2004). "Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data". The Lancet. 363 (9418): 1341–5. doi:10.1016/S0140-6736(04)16043-1. PMID 15110490.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Fava, M; Rush, AJ; Wisniewski, SR; Nierenberg, AA; Alpert, JE; McGrath, PJ; Thase, ME; Warden, D; Biggs, M; Luther, JF; Niederehe, G; Ritz, L; Trivedi, MH (2006). "A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report". The American Journal of Psychiatry. 163 (7): 1161–72. doi:10.1176/appi.ajp.163.7.1161. PMID 16816220.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Goss, AJ; Kaser, M; Costafreda, SG; Sahakian, BJ; Fu, CH (2013). "Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials". The Journal of Clinical Psychiatry. 74 (11): 1101–7. doi:10.4088/JCP.13r08560. PMID 24330897.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Brunton, Laurence L.; Chabner, Bruce; Knollmann, Björn C., บ.ก. (2011). Goodman and Gilman's The Pharmacological Basis of Therapeutics (12th ed.). New York: McGraw-Hill Professional. ISBN 978-0-07-162442-8.
Ernst E; Rand JI; Barnes J; Stevinson C (1998). "Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.)". European Journal of Clinical Pharmacology. 54 (8): 589–94. doi:10.1007/s002280050519. PMID 9860144. Collectively, the data suggest that hypericum is well tolerated, with an incidence of adverse reactions similar to that of placebo.
Taylor, D; Paton, C; Shitij, K (2012). The Maudsley prescribing guidelines in psychiatry. West Sussex: Wiley-Blackwell. ISBN 978-0-470-97948-8.
Bruijn, JA; Moleman, P; Mulder, PG; van den Broek, WW; van Hulst, AM; van der Mast, RC; van de Wetering, BJ (1996). "A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients". Psychopharmacology. 127 (3): 231–7. doi:10.1007/BF02246131. PMID 8912401.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Voican, CS; Corruble, E; Naveau, S; Perlemuter, G (Apr 2014). "Antidepressant-induced liver injury: a review for clinicians". The American Journal of Psychiatry. 171 (4): 404–15. doi:10.1176/appi.ajp.2013.13050709. PMID 24362450.
Joint Formulary Committee (2013). British National Formulary (BNF) (65 ed.). London, UK: Pharmaceutical Press. ISBN 978-0-85711-084-8.
Benazzi, F (1997). "Antidepressant-associated hypomania in outpatient depression: a 203-case study in private practice". J Affect Disord. 46 (1): 73–7. doi:10.1016/S0165-0327(97)00082-7. PMID 9387089.
Grant, Jon E.; Potenza, Marc N., บ.ก. (2012). The Oxford handbook of impulse control disorders. Oxford: Oxford University Press. ISBN 978-0-19-538971-5.
Serretti, A; Chiesa, A (2009). "Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis". J Clin Psychopharmacol. 29 (3): 259–66. doi:10.1097/JCP.0b013e3181a5233f. PMID 19440080.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Ozmenler, NK; Karlidere, T; Bozkurt, A; Yetkin, S; Doruk, A; Sutcigil, L; Cansever, A; Uzun, O; Ozgen, F; Ozsahin, A (2008). "Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors". Hum Psychopharmacol. 23 (4): 321–6. doi:10.1002/hup.929. PMID 18278806.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Nielsen, M; al., et (May 2012). "What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors". Addiction. 107 (5): 900–8. doi:10.1111/j.1360-0443.2011.03686.x. PMID 21992148.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Pies, R (Apr 2010). "Antidepressants Work, Sort of-Our System of Care Does Not". Journal of Clinical Psychopharmacology. 30 (2): 101–104. doi:10.1097/JCP.0b013e3181d52dea. PMID 20520282.
Taylor, D; Carol, P; Shitij, K (2012). The Maudsley prescribing guidelines in psychiatry. West Sussex: Wiley-Blackwell. ISBN 978-0-470-97969-3.
Nierenberg, AA; Fava, M; Trivedi, MH; Wisniewski, SR; Thase, ME; McGrath, PJ; Alpert, JE; Warden, D; Luther, JF; Niederehe, G; Lebowitz, B; Shores-Wilson, K; Rush, AJ (2006). "A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: A STAR*D report". American Journal of Psychiatry. 163 (9): 1519–30. doi:10.1176/appi.ajp.163.9.1519. PMID 16946176.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Kraus, MF; Burch, EA (1992). "Methylphenidate hydrochloride as an antidepressant: controversy, case studies, and review". South. Med. J. 85 (10): 985–91. doi:10.1097/00007611-199210000-00012. PMID 1411740.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Healy, David (1998). The Psychopharmacologists: Volume 2. A Hodder Arnold Publication. pp. 132-4. ISBN 978-1-86036-010-7.
Kuhn, R (1958). "The treatment of depressive states with G 22355 (imipramine hydrochloride)". The American Journal of Psychiatry. 115 (5): 459–64. PMID 13583250.
Lock, M; Nguyen, VK (2010). ""Local Biologies and Human Difference". An anthropology of biomedicine (1st ed.). Chichester, West Sussex: Wiley-Blackwell. pp. 83-109. ISBN 1-4051-1071-6.{{cite book}}: CS1 maint: uses authors parameter (ลิงก์)

archive.today

"PsychiatryOnline | APA Practice Guidelines | Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Third Edition". คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2014-02-19. สืบค้นเมื่อ 2016-10-03.

aspetjournals.org

jpet.aspetjournals.org

Wong, DT; Bymaster, FP; Horng, JS; Molloy, BB (1975). "A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3- (p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine". The Journal of Pharmacology and Experimental Therapeutics. 193 (3): 804–11. PMID 1151730. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-11-19. สืบค้นเมื่อ 2016-10-03.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)

books.google.com

Preskorn, SH; Ross, R; Stanga, CY (2004). "Selective Serotonin Reuptake Inhibitors". ใน Sheldon H. Preskorn; Hohn P. Feighner; Christina Y. Stanga; Ruth Ross (บ.ก.). Antidepressants: Past, Present and Future. Berlin: Springer. pp. 241–62. ISBN 978-3-540-43054-4.{{cite book}}: CS1 maint: uses authors parameter (ลิงก์)
Healy, D (2001). "The Antidepressant Drama". ใน Weissman, M.M. (บ.ก.). The treatment of depression: bridging the 21st century. American Psychiatric Pub. pp. 10–11. ISBN 978-0-88048-397-1. สืบค้นเมื่อ 2009-05-28.

cdc.gov

"Antidepressant Use in Persons Aged 12 and Over: United States, 2005-2008". www.cdc.gov. Products - Data Briefs - Number 76 - October 2011. Centers for Disease Control and Prevention. สืบค้นเมื่อ 2016-02-04.

cmcsb.com

"Tranquilizers". Cumberland Mountain Community Services. www.cmcsb.com. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2012-09-16. สืบค้นเมื่อ 2013-11-20.^{[แหล่งอ้างอิงทางการแพทย์ที่ไม่น่าเชื่อถือ?]}

doi.org

Linde, K; Kriston, L; Rücker, G; Jamila, S; Schumann, I; Meissner, K; Sigterman, K; Schneider, A (Feb 2015). "Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis". Ann Fam Med. 13 (1): 69–79. doi:10.1370/afm.1687. PMC 4291268. PMID 25583895. In network meta-analysis, tricyclic and tetracyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), a serotonin-noradrenaline reuptake inhibitor (SNRI; venlafaxine), a low-dose serotonin antagonist and reuptake inhibitor (SARI; trazodone) and hypericum extracts were found to be significantly superior to placebo, with estimated odds ratios between 1.69 and 2.03. There were no statistically significant differences between these drug classes. Reversible inhibitors of monoaminoxidase A (rMAO-As) and hypericum extracts were associated with significantly fewer dropouts because of adverse effects compared with TCAs, SSRIs, the SNRI, a noradrenaline reuptake inhibitor (NRI), and noradrenergic and specific serotonergic antidepressant agents (NaSSAs). ... TCAs and SSRIs have the most solid evidence base. Further agents (hypericum, rMAO-As, SNRI, NRI, NaSSAs, SARI) showed some positive results, but limitations of the currently available evidence makes a clear recommendation on their place in clinical practice difficult.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Linde, K; Berner, MM; Kriston, L (2008). "St John's wort for major depression". Cochrane Database Syst Rev (4): CD000448. doi:10.1002/14651858.CD000448.pub3. PMID 18843608.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Hamilton, M (1960). "A rating scale for depression". J. Neurol. Neurosurg. Psychiatr. 23: 56–62. doi:10.1136/jnnp.23.1.56. PMC 495331. PMID 14399272.
Kirsch, I; Moore, TJ; Scoboria, A; Nicholls, SS (2002). "The emperor's new drugs: An analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration". Prevention & Treatment. 5. doi:10.1037/1522-3736.5.1.523a.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Kirsch, I; Deacon, BJ; Huedo-Medina, TB; Scoboria, A; Moore, TJ; Johnson, BT (2008). "Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration". PLoS Medicine. 5 (2): e45. doi:10.1371/journal.pmed.0050045. PMC 2253608. PMID 18303940.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Fournier, JC; DeRubeis, RJ; Hollon, SD และคณะ (Jan 2010). "Antidepressant drug effects and depression severity: a patient-level meta-analysis". JAMA. 303 (1): 47–53. doi:10.1001/jama.2009.1943. PMC 3712503. PMID 20051569.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Borges, S; Chen, YF; Laughren, TP; Temple, R; Patel, HD; David, PA; Mathis, M; Unger, E; Yang, P; Khin, NA (2014). "Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration". J Clin Psychiatry. 75 (3): 205–14. doi:10.4088/JCP.13r08722. PMID 24717376.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Leucht, C; Huhn, M; Leucht, S (2012). Leucht, C (บ.ก.). "Amitriptyline versus placebo for major depressive disorder". Cochrane Database of Systematic Reviews. 12: CD009138. doi:10.1002/14651858.CD009138.pub2. PMID 23235671.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Zhou, X; Ravindran, AV; Qin, B; Del Giovane, C; Li, Q; Bauer, M; Liu, Y; Fang, Y; da Silva, T; Zhang, Y; Fang, L; Wang, X; Xie, P (Apr 2015). "Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis". J Clin Psychiatry. 76 (4): e487-98. doi:10.4088/JCP.14r09204. PMID 25919841. Quetiapine and aripiprazole appear to be the most robust evidence-based options for augmentation therapy in patients with treatment-resistant depression{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Walsh, BT; Seidman, SN; Sysko, R; Gould, M (2002). "Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing". JAMA. 287 (14): 1840–7. doi:10.1001/jama.287.14.1840. PMID 11939870.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Freeman, MP; Mischoulon, D; Tedeschini, E; Goodness, T; Cohen, LS; Fava, M; Papakostas, GI (2010). "Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants". J Clin Psychiatry. 71 (6): 682–8. doi:10.4088/JCP.10r05976blu. PMID 20573327.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Lee, K; Bacchetti, P; Sim, I (2008). Clarke, Mike (บ.ก.). "Publication of Clinical Trials Supporting Successful New Drug Applications: A Literature Analysis". PLoS Medicine. 5 (9): e191. doi:10.1371/journal.pmed.0050191. PMC 2553819. PMID 18816163.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Whittington, CJ; Kendall, T; Fonagy, P; Cottrell, D; Cotgrove, A; Boddington, E (2004). "Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data". The Lancet. 363 (9418): 1341–5. doi:10.1016/S0140-6736(04)16043-1. PMID 15110490.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Ebrahim, Shanil (2015). "Meta-analyses with industry involvement are massively published and report no caveats for antidepressants". Journal of Clinical Epidemology. doi:10.1016/j.jclinepi.2015.08.021. PMID 26399904.
Gibbons, RD; Hur, K; Brown, CH; Davis, JM; Mann, JJ (June 2012). "Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine". Archives of General Psychiatry. 69 (6): 572–9. doi:10.1001/archgenpsychiatry.2011.2044. PMC 3371295. PMID 22393205.
Taylor, MJ; Freemantle, N; Geddes, JR; Bhagwagar, Z (2006). "Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action: Systematic Review and Meta-analysis". Archives of General Psychiatry. 63 (11): 1217–23. doi:10.1001/archpsyc.63.11.1217. PMC 2211759. PMID 17088502.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Fava, M; Rush, AJ; Wisniewski, SR; Nierenberg, AA; Alpert, JE; McGrath, PJ; Thase, ME; Warden, D; Biggs, M; Luther, JF; Niederehe, G; Ritz, L; Trivedi, MH (2006). "A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report". The American Journal of Psychiatry. 163 (7): 1161–72. doi:10.1176/appi.ajp.163.7.1161. PMID 16816220.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Trivedi, MH; Fava, M; Wisniewski, SR; Thase, ME; Quitkin, F; Warden, D; Ritz, L; Nierenberg, AA; Lebowitz, BD; Biggs, MM; Luther, JF; Shores-Wilson, K; Rush, AJ (2006). "Medication Augmentation after the Failure of SSRIs for Depression". New England Journal of Medicine. 354 (12): 1243–52. doi:10.1056/NEJMoa052964. PMID 16554526.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Trivedi, MH; Rush, AJ; Wisniewski, SR; Nierenberg, AA; Warden, D; Ritz, L; Norquist, G; Howland, RH; Lebowitz, B; McGrath, PJ; Shores-Wilson, K; Biggs, MM; Balasubramani, GK; Fava, M (2006). "Evaluation of Outcomes with Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice". American Journal of Psychiatry. 163 (1): 28–40. doi:10.1176/appi.ajp.163.1.28. PMID 16390886.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Warden, D; Trivedi, MH; Wisniewski, SR; Davis, L; Nierenberg, AA; Gaynes, BN; Zisook, S; Hollon, SD; Balasubramani, GK; Howland, R; Fava, M; Stewart, JW; Rush, AJ (2007). "Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report". Am J Psychiatry. 164 (8): 1189–97. doi:10.1176/appi.ajp.2007.06071225. PMID 17671281.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Rush, AJ; Trivedi, MH; Wisniewski, SR; Stewart, JW; Nierenberg, AA; Thase, ME; Ritz, L; Biggs, MM; Warden, D; Luther, JF; Shores-Wilson, K; Niederehe, G; Fava, M (2006). "Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression". New England Journal of Medicine. 354 (12): 1231–42. doi:10.1056/NEJMoa052963. PMID 16554525.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Rush, AJ; Trivedi, MH; Wisniewski, SR และคณะ (Nov 2006). "Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report". Am J Psychiatry. 163 (11): 1905–17. doi:10.1176/appi.ajp.163.11.1905. PMID 17074942.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Warden, D; Rush, AJ; Trivedi, MH; Fava, M; Wisniewski, SR (2007). "The STAR*D Project results: A comprehensive review of findings". Current Psychiatry Reports. 9 (6): 449–59. doi:10.1007/s11920-007-0061-3. PMID 18221624.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Baghai, TC; Möller, HJ; Rupprecht, R (2006). "Recent Progress in Pharmacological and Non-Pharmacological Treatment Options of Major Depression". Current Pharmaceutical Design. 12 (4): 503–15. doi:10.2174/138161206775474422. PMID 16472142.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Ruhé, HG; Huyser, J; Swinkels, JA; Schene, AH (2006). "Switching Antidepressants After a First Selective Serotonin Reuptake Inhibitor in Major Depressive Disorder". The Journal of Clinical Psychiatry. 67 (12): 1836–55. doi:10.4088/JCP.v67n1203. PMID 17194261.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Byrne, SE; Rothschild, AJ (1998). "Loss of Antidepressant Efficacy During Maintenance Therapy". The Journal of Clinical Psychiatry. 59 (6): 279–88. doi:10.4088/JCP.v59n0602. PMID 9671339.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Bschor, T; Baethge, C (2010). "No evidence for switching the antidepressant: Systematic review and meta-analysis of RCTs of a common therapeutic strategy". Acta Psychiatrica Scandinavica. 121 (3): 174–9. doi:10.1111/j.1600-0447.2009.01458.x. PMID 19703121.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
DeBattista, C; Lembke, A (2005). "Update on augmentation of antidepressant response in resistant depression". Current Psychiatry Reports. 7 (6): 435–40. doi:10.1007/s11920-005-0064-x. PMID 16318821.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Lam, RW; Wan, DD; Cohen, NL; Kennedy, SH (2002). "Combining Antidepressants for Treatment-Resistant Depression". The Journal of Clinical Psychiatry. 63 (8): 685–93. doi:10.4088/JCP.v63n0805. PMID 12197448.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Goss, AJ; Kaser, M; Costafreda, SG; Sahakian, BJ; Fu, CH (2013). "Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials". The Journal of Clinical Psychiatry. 74 (11): 1101–7. doi:10.4088/JCP.13r08560. PMID 24330897.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Geddes, JR; Carney, SM; Davies, C; Furukawa, TA; Kupfer, DJ; Frank, E; Goodwin, GM (2003). "Relapse prevention with antidepressant drug treatment in depressive disorders: A systematic review". The Lancet. 361 (9358): 653–61. doi:10.1016/S0140-6736(03)12599-8. PMID 12606176.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Fava, GA; Offidani, E (2011). "The mechanisms of tolerance in antidepressant action". Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35 (7): 1593–602. doi:10.1016/j.pnpbp.2010.07.026. PMID 20728491.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Fava, GA; Park, SK; Sonino, N (2006). "Treatment of recurrent depression". Expert Review of Neurotherapeutics. 6 (11): 1735–40. doi:10.1586/14737175.6.11.1735. PMID 17144786.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Petersen, TJ (2006). "Enhancing the efficacy of antidepressants with psychotherapy". Journal of Psychopharmacology. 20 (3 suppl): 19–28. doi:10.1177/1359786806064314. PMID 16644768.
Ernst E; Rand JI; Barnes J; Stevinson C (1998). "Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.)". European Journal of Clinical Pharmacology. 54 (8): 589–94. doi:10.1007/s002280050519. PMID 9860144. Collectively, the data suggest that hypericum is well tolerated, with an incidence of adverse reactions similar to that of placebo.
Cipriani, A; Furukawa, TA; Salanti, G; Geddes, JR; Higgins, JP; Churchill, R; Watanabe, N; Nakagawa, A; Omori, IM; McGuire, H; Tansella, M; Barbui, C (2009). "Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis". Lancet. 373 (9665): 746–58. doi:10.1016/S0140-6736(09)60046-5. PMID 19185342.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
White, N; Litovitz, T; Clancy, C (2008). "Suicidal antidepressant overdoses: a comparative analysis by antidepressant type". J Med Toxicol. 4 (4): 238–50. doi:10.1007/BF03161207. PMC 3550116. PMID 19031375.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Bruijn, JA; Moleman, P; Mulder, PG; van den Broek, WW; van Hulst, AM; van der Mast, RC; van de Wetering, BJ (1996). "A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients". Psychopharmacology. 127 (3): 231–7. doi:10.1007/BF02246131. PMID 8912401.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Bruijn, JA; Moleman, P; Mulder, PG; van den Broek, WW (1999). "Depressed in-patients respond differently to imipramine and mirtazapine". Pharmacopsychiatry. 32 (3): 87–92. doi:10.1055/s-2007-979200. PMID 10463374.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
van Moffaert, M; de Wilde, J; Vereecken, A; Dierick, M; Evrard, JL; Wilmotte, J; Mendlewicz, J (Mar 1995). "Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression". Int Clin Psychopharmacol. 10 (1): 3–9. doi:10.1097/00004850-199503000-00001. PMID 7622801.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Goodwin, GM (2009). "Clinical studies on the efficacy of agomelatine on depressive symptoms". CNS Drugs. 23 Suppl 2: 35–9. doi:10.2165/11318650-000000000-00000. PMID 19708724.
Voican, CS; Corruble, E; Naveau, S; Perlemuter, G (Apr 2014). "Antidepressant-induced liver injury: a review for clinicians". The American Journal of Psychiatry. 171 (4): 404–15. doi:10.1176/appi.ajp.2013.13050709. PMID 24362450.
Fishback, JA; Robson, MJ; Xu, YT; Matsumoto, RR (2010). "Sigma receptors: potential targets for a new class of antidepressant drug". Pharmacol. Ther. 127 (3): 271–82. doi:10.1016/j.pharmthera.2010.04.003. PMC 3993947. PMID 20438757.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Kishimoto, A; Todani, A; Miura, J; Kitagaki, T; Hashimoto, K (2010). "The opposite effects of fluvoxamine and sertraline in the treatment of psychotic major depression: a case report". Ann Gen Psychiatry. 9: 23. doi:10.1186/1744-859X-9-23. PMC 2881105. PMID 20492642.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Schmitt, JA; Ramaekers, JG; Kruizinga, MJ; van Boxtel, MP; Vuurman, EF; Riedel, WJ (2002). "Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man". J. Psychopharmacol. 16 (3): 207–14. doi:10.1177/026988110201600303. PMID 12236626.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Kapczinski, F; Lima, MS; Souza, JS; Schmitt, R (2003). Kapczinski, Flavio FK (บ.ก.). "Antidepressants for generalized anxiety disorder". Cochrane Database Syst Rev (2): CD003592. doi:10.1002/14651858.CD003592. PMID 12804478.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Arroll, B; Elley, CR; Fishman, T; Goodyear-Smith, FA; Kenealy, T; Blashki, G; Kerse, N; Macgillivray, S (2009). Arroll, Bruce (บ.ก.). "Antidepressants versus placebo for depression in primary care". The Cochrane Database of Systematic Reviews (3): CD007954. doi:10.1002/14651858.CD007954. PMID 19588448.{{cite journal}}: CS1 maint: multiple names: authors list (ลิงก์)
Fineberg, NA; Brown, A; Reghunandanan, S; Pampaloni, I (2012). "Evidence-based pharmacotherapy of obsessive-compulsive disorder". The International Journal of Neuropsychopharmacology. 15 (8): 1173–91. doi:10.1017/S1461145711001829. PMID 22226028.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Flament, MF; Bissada, H; Spettigue, W (Mar 2012). "Evidence-based pharmacotherapy of eating disorders". The International Journal of Neuropsychopharmacology. 15 (2): 189–207. doi:10.1017/S1461145711000381. PMID 21414249.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Häuser, W; Wolfe, F; Tölle, T; Uçeyler, N; Sommer, C (Apr 2012). "The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis". CNS Drugs. 26 (4): 297–307. doi:10.2165/11598970-000000000-00000. PMID 22452526.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
doi:10.1136/ard.2007.071522
This citation will be automatically completed in the next few minutes. You can jump the queue or expand by hand Full Article PDF (135 KB)
Lunn, MP; Hughes, RA; Wiffen, PJ (2014). "Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia". Cochrane Database Syst Rev. 1: CD007115. doi:10.1002/14651858.CD007115.pub3. PMID 24385423.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
update Moore, RA; Derry, S; Aldington, D; Cole, P; Wiffen, PJ (2012). "Amitriptyline for neuropathic pain and fibromyalgia in adults". Cochrane Database Syst Rev. 12: CD008242. doi:10.1002/14651858.CD008242.pub2. PMID 23235657.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Boyer, EW; Shannon, M (2005). "The serotonin syndrome" (PDF). N. Engl. J. Med. 352 (11): 1112–20. doi:10.1056/NEJMra041867. PMID 15784664. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2013-06-18.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Mason, PJ; Morris, VA; Balcezak, TJ (2000). "Serotonin syndrome. Presentation of 2 cases and review of the literature". Medicine. 79 (4): 201–9. doi:10.1097/00005792-200007000-00001. PMID 10941349.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Rao, Sathyanarayana TS; Yeragani, VK (2009). "Hypertensive crisis and cheese". Indian J Psychiatry. 51 (1): 65–6. doi:10.4103/0019-5545.44910. PMC 2738414. PMID 19742203.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Paykel, ES (1995). "Clinical efficacy of reversible and selective inhibitors of monoamine oxidase A in major depression". Acta Psychiatr Scand Suppl. 386: 22–7. doi:10.1111/j.1600-0447.1995.tb05920.x. PMID 7717091.
Malm, H (Dec 2012). "Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome". Therapeutic Drug Monitoring. 34 (6): 607–14. doi:10.1097/FTD.0b013e31826d07ea. PMID 23042258.
Rahimi, R; Nikfar, S; Abdollahi, M (2006). "Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials". Reproductive Toxicology (Elmsford, N.Y.). 22 (4): 571–575. doi:10.1016/j.reprotox.2006.03.019. PMID 16720091.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Nikfar, S; Rahimi, R; Hendoiee, N; Abdollahi, M (2012). "Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysis". Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 20 (1): 75. doi:10.1186/2008-2231-20-75. PMC 3556001. PMID 23351929.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Huang, H; Coleman, S; Bridge, JA; Yonkers, K; Katon, W (2014). "A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight". General Hospital Psychiatry. 36 (1): 13–8. doi:10.1016/j.genhosppsych.2013.08.002. PMC 3877723. PMID 24094568.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Koren, G; Nordeng, HM (Feb 2013). "Selective serotonin reuptake inhibitors and malformations: case closed?". Seminars in Fetal & Neonatal Medicine. 18 (1): 19–22. doi:10.1016/j.siny.2012.10.004. PMID 23228547.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Ross, Lori E.; Grigoriadis, Sophie; Mamisashvili, Lana; VonderPorten, Emily H.; Roerecke, Michael; Rehm, Jürgen; Dennis, Cindy-Lee; Koren, Gideon; Steiner, Meir; Mousmanis, Patricia; Cheung, Amy (2013-04-01). "Selected Pregnancy and Delivery Outcomes After Exposure to Antidepressant Medication". JAMA Psychiatry. 70 (4): 436. doi:10.1001/jamapsychiatry.2013.684.
di Scalea, T Lanza; Wisner, KL (2009). "Antidepressant Medication Use During Breastfeeding". Clinical Obstetrics and Gynecology. 52 (3): 483–97. doi:10.1097/GRF.0b013e3181b52bd6. PMC 2902256. PMID 19661763.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Goldberg, JF; Truman, CJ (2003). "Antidepressant-induced mania: An overview of current controversies". Bipolar Disorders. 5 (6): 407–20. doi:10.1046/j.1399-5618.2003.00067.x. PMID 14636364.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Benazzi, F (1997). "Antidepressant-associated hypomania in outpatient depression: a 203-case study in private practice". J Affect Disord. 46 (1): 73–7. doi:10.1016/S0165-0327(97)00082-7. PMID 9387089.
Stone, M; Laughren, T; Jones, ML; Levenson, M; Holland, PC; Hughes, A; Hammad, TA; Temple, R; Rochester, G (2009). "Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration". BMJ. 339: b2880. doi:10.1136/bmj.b2880. PMC 2725270. PMID 19671933.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Friedman, RA; Leon, AC (2007). "Expanding the black box - depression, antidepressants, and the risk of suicide". N. Engl. J. Med. 356 (23): 2343–6. doi:10.1056/NEJMp078015. PMID 17485726.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
update Cox, GR; Callahan, P; Churchill, R; Hunot, V; Merry, SN; Parker, AG; Hetrick, SE (2012). "Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents". Cochrane Database Syst Rev. 11: CD008324. doi:10.1002/14651858.CD008324.pub2. PMID 23152255.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Healy, D; Aldred, G (2005). "Antidepressant drug use and the risk of suicide" (PDF). International Review of Psychiatry. 17: 163–172. doi:10.1080/09540260500071624. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2013-10-21. สืบค้นเมื่อ 2016-10-03.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Csoka, AB; Csoka, A; Bahrick, A; Mehtonen, OP (2008). "Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors". J Sex Med. 5 (1): 227–33. doi:10.1111/j.1743-6109.2007.00630.x. PMID 18173768.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Serretti, A; Chiesa, A (2009). "Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis". J Clin Psychopharmacol. 29 (3): 259–66. doi:10.1097/JCP.0b013e3181a5233f. PMID 19440080.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Keltner, NL; McAfee, KM; Taylor, CL (2009). "Biological Perspectives". Perspectives in Psychiatric Care. 38 (3): 111–6. doi:10.1111/j.1744-6163.2002.tb00665.x. PMID 12385082.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Ozmenler, NK; Karlidere, T; Bozkurt, A; Yetkin, S; Doruk, A; Sutcigil, L; Cansever, A; Uzun, O; Ozgen, F; Ozsahin, A (2008). "Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors". Hum Psychopharmacol. 23 (4): 321–6. doi:10.1002/hup.929. PMID 18278806.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Labbate, LA; Grimes, JB; Hines, A; Pollack, MH (Dec 1997). "Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction". Annals of Clinical Psychiatry. 9 (4): 241–5. doi:10.3109/10401239709147804. PMID 9511948.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Stimmel, GL; Dopheide, JA; Stahl, SM (1997). "Mirtazapine: An antidepressant with noradrenergic and specific serotonergic effects". Pharmacotherapy. 17 (1): 10–21. doi:10.1002/j.1875-9114.1997.tb03674.x. PMID 9017762.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Li, Z; Maglione, M; Tu, W; Mojica, W; Arterburn, D; Shugarman, LR; Hilton, L; Suttorp, M; Solomon, V; Shekelle, PG; Morton, SC (Apr 2005). "Meta-analysis: pharmacologic treatment of obesity". Ann. Intern. Med. 142 (7): 532–46. doi:10.7326/0003-4819-142-7-200504050-00012. PMID 15809465.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Haddad, P. (2001). "Antidepressant discontinuation syndromes". Drug Saf. 24 (3): 183–97. doi:10.2165/00002018-200124030-00003. PMID 11347722.
Haddad, P.M.; Anderson, I.M. (2007). "Recognising and managing antidepressant discontinuation symptoms". Advances in Psychiatric Treatment. 13 (6): 447–457. doi:10.1192/apt.bp.105.001966.
Renoir, T (Apr 2013). "Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved". Front Pharmacol. 4: 45. doi:10.3389/fphar.2013.00045. PMC 3627130. PMID 23596418.
Haddad, PM; Dursun, SM (Jan 2008). "Neurological complications of psychiatric drugs: clinical features and management". Hum Psychopharmacol. 23 (Suppl 1): 15–26. doi:10.1002/hup.918. PMID 18098217.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Tamam, L.; Ozpoyraz, N. (2002, January-February). "Selective Serotonin Reuptake Inhibitor Discontinuation Syndrome: A Review". Advances in Therapy. 19 (1): 17–26. doi:10.1007/BF02850015. PMID 12008858. สืบค้นเมื่อ 2012-11-28. {{cite journal}}: ตรวจสอบค่าวันที่ใน: |date= (help)
Evans, EA; Sullivan, MA (Aug 2014). "Abuse and misuse of antidepressants". Subst Abuse Rehabil. 5: 107–20. doi:10.2147/SAR.S37917. PMID 25187753.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Nielsen, M; al., et (May 2012). "What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors". Addiction. 107 (5): 900–8. doi:10.1111/j.1360-0443.2011.03686.x. PMID 21992148.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Brady, K (May 2012). "Withdrawal or dependence: a matter of context. Comment on: What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors". Addiction. 107 (5): 910–1. doi:10.1111/j.1360-0443.2012.03862.x. PMID 22471576.
Lader, M (May 2012). "Dependence and withdrawal: comparison of the benzodiazepines and selective serotonin re-uptake inhibitors. Comment on: What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors". Addiction. 107 (5): 909–10. doi:10.1111/j.1360-0443.2011.03736.x. PMID 22471575.
Maes, M; Yirmyia, R; Noraberg, J; Brene, S; Hibbeln, J; Perini, G; Kubera, M; Bob, P; Lerer, B; Maj, M (Mar 2009). "The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression". Metabolic Brain Disease. 24 (1): 27–53. doi:10.1007/s11011-008-9118-1. PMID 19085093.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Sanacora, G; Treccani, G; Popoli, M (Jan 2012). "Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders". Neuropharmacology. 62 (1): 63–77. doi:10.1016/j.neuropharm.2011.07.036. PMC 3205453. PMID 21827775.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Menke, A; Klengel, T; Binder, EB (2012). "Epigenetics, depression and antidepressant treatment". Current Pharmaceutical Design. 18 (36): 5879–5889. doi:10.2174/138161212803523590. PMID 22681167.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Vialou, V; Feng, J; Robison, AJ; Nestler, EJ (Jan 2013). "Epigenetic mechanisms of depression and antidepressant action". Annual Review of Pharmacology and Toxicology. 53 (1): 59–87. doi:10.1146/annurev-pharmtox-010611-134540. PMID 23020296.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Fournier, JC; DeRubeis, RJ; Hollon, SD; Dimidjian, S; Amsterdam, JD; Shelton, RC; Fawcett, J (Jan 2010). "Antidepressant Drug Effects and Depression Severity". JAMA: The Journal of the American Medical Association. 303 (1): 47–53. doi:10.1001/jama.2009.1943. PMC 3712503. PMID 20051569.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Pies, R (Apr 2010). "Antidepressants Work, Sort of-Our System of Care Does Not". Journal of Clinical Psychopharmacology. 30 (2): 101–104. doi:10.1097/JCP.0b013e3181d52dea. PMID 20520282.
Cashman, JR; Ghirmai, S (2009). "Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression". Bioorganic & Medicinal Chemistry. 17 (19): 6890–7. doi:10.1016/j.bmc.2009.08.025. PMID 19740668.
Hughes, ZA; Starr, KR; Langmead, CJ และคณะ (Mar 2005). "Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone". European Journal of Pharmacology. 510 (1–2): 49–57. doi:10.1016/j.ejphar.2005.01.018. PMID 15740724.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Wee, S; Woolverton, WL (Sep 2004). "Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine". Drug and Alcohol Dependence. 75 (3): 271–6. doi:10.1016/j.drugalcdep.2004.03.010. PMID 15283948.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Gasior, M; Bergman, J; Kallman, MJ; Paronis, CA (Apr 2005). "Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys". Neuropsychopharmacology. 30 (4): 758–64. doi:10.1038/sj.npp.1300593. PMID 15526000.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Rothman, RB; Baumann, MH; Dersch, CM และคณะ (Jan 2001). "Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin". Synapse. 39 (1): 32–41. doi:10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3. PMID 11071707.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Tatsumi, M; Groshan, K; Blakely, RD; Richelson, E (1997). "Pharmacological profile of antidepressants and related compounds at human monoamine transporters". Eur J Pharmacol. 340 (2–3): 249–258. doi:10.1016/S0014-2999(97)01393-9. PMID 9537821.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Gillman, PK (July 2007). "Tricyclic antidepressant pharmacology and therapeutic drug interactions updated". British Journal of Pharmacology. 151 (6): 737–48. doi:10.1038/sj.bjp.0707253. PMC 2014120. PMID 17471183.
Rénéric, JP; Lucki, I (Mar 1998). "Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test". Psychopharmacology. 136 (2): 190–7. doi:10.1007/s002130050555. PMID 9551776.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Heimberg, RG; Liebowitz, MR; Hope, DA; และคณะ. "Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome". Arch Gen Psychiatry. 55 (12): 1133–41. doi:10.1001/archpsyc.55.12.1133.
Jarrett, RB; Schaffer, M; McIntire, D; Witt-Browder, A; Kraft, D; Risser, RC. "Treatment of atypical depression with cognitive therapy or phenelzine: A double-blind, placebo-controlled trial". Arch Gen Psychiatry. 56 (5): 431–7. doi:10.1001/archpsyc.56.5.431.
Liebowitz, MR; Quitkin, FM; Stewart, JW; และคณะ. "Phenelzine v imipramine in atypical depression: A preliminary report". Arch Gen Psychiatry. 41 (7): 669–77. doi:10.1001/archpsyc.1984.01790180039005.
Walsh, B; Stewart, JW; Roose, SP; Gladis, M; Glassman, AH. "Treatment of bulimia with phenelzine: A double-blind, placebo-controlled study". Arch Gen Psychiatry. 41 (11): 1105–9. doi:10.1001/archpsyc.1983.01790220095015.
Rothschild, R; Quitkin, HM; Quitkin, FM; Stewart, JW; Ocepek-Welikson, K; McGrath, PJ และคณะ. "A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives". International Journal of Eating Disorders. 15 (1): 1–9. doi:10.1002/1098-108X(199401)15:1<1::AID-EAT2260150102>3.0.CO;2-E.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Walsh, BT; Stewart, JW; Roose, SP; Gladis, M; Glassman, AH. "A double-blind trial of phenelzine in bulimia". Journal of Psychiatric Research. 19 (2–3): 485–9. doi:10.1016/0022-3956(85)90058-5.
Walsh, B; Gladis, M; Roose, SP; Stewart, JW; Stetner, F; Glassman, AH (May 1988). "Phenelzine vs placebo in 50 patients with bulimia". Arch Gen Psychiatry. 45 (5): 471–5. doi:10.1001/archpsyc.1988.01800290091011. PMID 3282482.
Davidson, J; Ingram, J; Kilts, C (1987). "A pilot study of phenelzine in the treatment of post-traumatic stress disorder". The British Journal of Psychiatry. 150: 252–5. doi:10.1192/bjp.150.2.252.
Soloff, PH; Cornelius, J; George, A; Nathan, S; Perel, JM; Ulrich, RF. "Efficacy of phenelzine and haloperidol in borderline personality disorder". Arch Gen Psychiatry. 50 (5): 377–85. doi:10.1001/archpsyc.1993.01820170055007.
Liebowitz, MR; Hollander, E; Schneier, F; Campeas, R; Welkowitz, L; Hatterer, J; Fallon, B (1990). "Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders". Acta Psychiatr Scand Suppl. 360: 29–34. doi:10.1111/j.1600-0447.1990.tb05321.x. PMID 2248064.
Bauer, M; Dopfmer, S (1999). "Lithium augmentation in treatment-resistant depression: Meta-analysis of placebo-controlled studies". Journal of Clinical Psychopharmacology. 19 (5): 427–34. doi:10.1097/00004714-199910000-00006. PMID 10505584.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Guzzetta, F; Tondo, L; Centorrino, F; Baldessarini, RJ (Mar 2007). "Lithium treatment reduces suicide risk in recurrent major depressive disorder". J Clin Psychiatry. 68 (3): 380–83. doi:10.4088/JCP.v68n0304. PMID 17388706.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Nierenberg, AA; Fava, M; Trivedi, MH; Wisniewski, SR; Thase, ME; McGrath, PJ; Alpert, JE; Warden, D; Luther, JF; Niederehe, G; Lebowitz, B; Shores-Wilson, K; Rush, AJ (2006). "A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: A STAR*D report". American Journal of Psychiatry. 163 (9): 1519–30. doi:10.1176/appi.ajp.163.9.1519. PMID 16946176.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Kraus, MF; Burch, EA (1992). "Methylphenidate hydrochloride as an antidepressant: controversy, case studies, and review". South. Med. J. 85 (10): 985–91. doi:10.1097/00007611-199210000-00012. PMID 1411740.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Orr, K; Taylor, D (2007). "Psychostimulants in the treatment of depression : a review of the evidence". CNS Drugs. 21 (3): 239–57. doi:10.2165/00023210-200721030-00004. PMID 17338594.
Weber, MM; Emrich, HM (1988). "Current and Historical Concepts of Opiate Treatment in Psychiatric Disorders". International Clinical Psychopharmacology. 3 (3): 255–66. doi:10.1097/00004850-198807000-00007. PMID 3153713.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Heal, DJ; Smith, SL; Gosden, J; Nutt, DJ (June 2013). "Amphetamine, past and present - a pharmacological and clinical perspective". J. Psychopharmacol. 27 (6): 479–96. doi:10.1177/0269881113482532. PMC 3666194. PMID 23539642.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Czygan, FC (2003). "Kulturgeschichte und Mystik des Johanniskrauts: Vom 2500 Jahre alten Apotropaikum zum aktuellen Antidepressivum" [From a 2500-year-old apotropic comes a current antidepressive. The cultural history and mistique of St. John's wort]. Pharmazie in unserer Zeit (ภาษาเยอรมัน). 32 (3): 184–90. doi:10.1002/pauz.200390062. PMID 12784538.
Selikoff, IJ; Robitzek, EH (1952). "Tuberculosis Chemotherapy with Hydrazine Derivatives of Isonicotinic Acid". CHEST Journal. 21 (4): 385–438. doi:10.1378/chest.21.4.385. PMID 14906149.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Robitzek, EH; Selikoff, IJ; Mamlok, E; Tendlau, A (1953). "Isoniazid and Its Isopropyl Derivative in the Therapy of Tuberculosis in Humans: Comparative Therapeutic and Toxicologic Properties". CHEST Journal. 23 (1): 1–15. doi:10.1378/chest.23.1.1. PMID 12998444.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
López-Muñoz, F; Alamo, C; Juckel, G; Assion, HJ (2007). "Half a Century of Antidepressant Drugs". Journal of Clinical Psychopharmacology. 27 (6): 555–9. doi:10.1097/jcp.0b013e3181bb617. PMID 18004120.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Healy, D (1999). "The Three Faces of the Antidepressants: A Critical Commentary on the Clinical-Economic Context of Diagnosis". The Journal of Nervous & Mental Disease. 187 (3): 174–80. doi:10.1097/00005053-199903000-00007. PMID 10086474.
Pletscher, A (1991). "The discovery of antidepressants: A winding path". Experientia. 47 (1): 4–8. doi:10.1007/BF02041242. PMID 1999242.
Domino, EF (1999). "History of modern psychopharmacology: A personal view with an emphasis on antidepressants". Psychosomatic Medicine. 61 (5): 591–8. doi:10.1097/00006842-199909000-00002. PMID 10511010.
Freeman, H (1996). "Tolerability and safety of novel antidepressants". European Psychiatry. 11: 206s. doi:10.1016/0924-9338(96)88597-X.
Linde, K; Ramirez, G; Mulrow, CD; Pauls, A; Weidenhammer, W; Melchart, D (1996). "St John's wort for depression—an overview and meta-analysis of randomised clinical trials". BMJ. 313 (7052): 253–8. doi:10.1136/bmj.313.7052.253. PMC 2351679. PMID 8704532.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Müller, WE (2003). "Current St. John's wort research from mode of action to clinical efficacy". Pharmacological Research. 47 (2): 101–9. doi:10.1016/S1043-6618(02)00266-9. PMID 12543057.
Nathan, PJ (2001). "Hypericum perforatum (St John's Wort) : A non-selective reuptake inhibitor? A review of the recent advances in its pharmacology". Journal of Psychopharmacology. 15 (1): 47–54. doi:10.1177/026988110101500109. PMID 11277608.
Ecks, S (2005). "Pharmaceutical Citizenship: Antidepressant Marketing and the Promise of Demarginalization in India". Anthropology & Medicine. 12 (3): 239–254. doi:10.1080/13648470500291360.
Nentwig, G (2007). "Effects of pharmaceuticals on aquatic invertebrates. Part II: the antidepressant drug fluoxetine". Arch. Environ. Contam. Toxicol. 52 (2): 163–70. doi:10.1007/s00244-005-7190-7. PMID 17160491.
Zhou, Z; Zhen, J; Karpowich, NK; Goetz, RM; Law, CJ; Reith, ME; Wang, DN (2007). "LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake". Science. 317 (5843): 1390–3. doi:10.1126/science.1147614. PMC 3711652. PMID 17690258.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Brooks, BW; Chambliss, CK; Stanley, JK; Ramirez, A; Banks, KE; Johnson, RD; Lewis, RJ (2005). "Determination of select antidepressants in fish from an effluent-dominated stream". Environ. Toxicol. Chem. 24 (2): 464–9. doi:10.1897/04-081r.1. PMID 15720009.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Fent, K; Weston, AA; Caminada, D (2006). "Ecotoxicology of human pharmaceuticals". Aquat. Toxicol. 76 (2): 122–59. doi:10.1016/j.aquatox.2005.09.009. PMID 16257063.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Perreault, HA; Semsar, K; Godwin, J (2003). "Fluoxetine treatment decreases territorial aggression in a coral reef fish". Physiol. Behav. 79 (4–5): 719–24. doi:10.1016/S0031-9384(03)00211-7. PMID 12954414.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Huber, R; Smith, K; Delago, A; Isaksson, K; Kravitz, EA (1997). "Serotonin and aggressive motivation in crustaceans: altering the decision to retreat". Proc. Natl. Acad. Sci. U.S.A. 94 (11): 5939–42. doi:10.1073/pnas.94.11.5939. PMC 20885. PMID 9159179.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Di Poi, C; Darmaillacq, AS; Dickel, L; Boulouard, M; Bellanger, C (2013). "Effects of perinatal exposure to waterborne fluoxetine on memory processing in the cuttlefish Sepia officinalis". Aquat. Toxicol. 132–133: 84–91. doi:10.1016/j.aquatox.2013.02.004. PMID 23474317.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)

dx.doi.org

Gasior, M; Bergman, J; Kallman, MJ; Paronis, CA (Apr 2005). "Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys". Neuropsychopharmacology. 30 (4): 758–64. doi:10.1038/sj.npp.1300593. PMID 15526000.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)

elsevier.com

linkinghub.elsevier.com

Hughes, ZA; Starr, KR; Langmead, CJ และคณะ (Mar 2005). "Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone". European Journal of Pharmacology. 510 (1–2): 49–57. doi:10.1016/j.ejphar.2005.01.018. PMID 15740724.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Wee, S; Woolverton, WL (Sep 2004). "Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine". Drug and Alcohol Dependence. 75 (3): 271–6. doi:10.1016/j.drugalcdep.2004.03.010. PMID 15283948.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)

enfa-europe.eu

doi:10.1136/ard.2007.071522
This citation will be automatically completed in the next few minutes. You can jump the queue or expand by hand Full Article PDF (135 KB)

fda.gov

"FDA Advising of Risk of Birth Defects with Paxil" (Press release). U.S. Food and Drug Administration. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-12-03. สืบค้นเมื่อ 2012-11-29.
"Antidepressant Use in Children, Adolescents, and Adults". FDA.
"FDA Medication Guide for Antidepressants" (PDF). สืบค้นเมื่อ 2014-06-05.

accessdata.fda.gov

"Sertraline prescribing information" (PDF). FDA. สืบค้นเมื่อ 2015-01-30.

gipdatabank.nl

"GIPdatabank". Gipdatabank.nl. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2008-12-06. สืบค้นเมื่อ 2008-11-06.

guardian.co.uk

Davis, Rowenna (2010-06-11). "Antidepressant Use Rises as Recession Feeds Wave of Worry". The Guardian. London. เก็บจากแหล่งเดิมเมื่อ 2010-06-15. สืบค้นเมื่อ 2010-07-01.

guidelines.gov

"National Guideline Clearinghouse | Practice guideline for the treatment of patients with eating disorders". คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-05-25. สืบค้นเมื่อ 2016-10-03.

jpharmacol.com

Sivagnanam, G (2012). "Antidepressants". Journal of Pharmacology and Pharmacotherapeutics. 3 (3): 287–8. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2018-07-01. สืบค้นเมื่อ 2016-10-03.

latimes.com

"FDA approves a new antidepressant: Brintellix". Los Angeles Times. 2013.

mayoclinic.com

"Depression (major depression) : Treatment and drugs". Mayo Clinic Staff.

medicinescomplete.com

Royal Pharmaceutical Society of Great Britain. MARTINDALE - The Complete Drug Reference. Pharmaceutical Press. เก็บจากแหล่งเดิมเมื่อ 2013-07-26. สืบค้นเมื่อ 2013-10-31.

medscape.com

"Medscape Log In". คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-04-13. สืบค้นเมื่อ 2016-10-03.

reference.medscape.com

"mirtazapine (Rx) - Remeron, Remeron SolTab". Medscape. WebMD. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-10-29. สืบค้นเมื่อ 2013-11-19.

merckmanuals.com

"Depressive Disorders". Merck Manual. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-12-05. สืบค้นเมื่อ 2012-11-30.

modernmedicine.com

drugtopics.modernmedicine.com

"Top 200 generic drugs by units in 2010" (PDF). คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2012-12-15.
"Top 200 brand drugs by units in 2010" (PDF). คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2012-04-22.

nice.org.uk

"Depression in adults: The treatment and management of depression in adults". NICE guidelines [CG90]. National Institute for Health and Care Excellence (UK). Oct 2009. สืบค้นเมื่อ 2015-09-23.
"Depression in Adults (update)" (PDF). National Collaborating Centre for Mental Health Commissioned by the National Institute for Health and Care Excellence. www.nice.org.uk. pp. 282–292. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2013-06-12. สืบค้นเมื่อ 2013-11-20.
"Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults" (PDF). NICE. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2012-10-21. สืบค้นเมื่อ 2013-02-20.
"Obsessive-compulsive disorder: Core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder" (PDF). Nov 2005. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2008-12-06. สืบค้นเมื่อ 2016-10-03.
"Eating disorders in over 8s: management" (PDF). NICE. Jan 2004.
"Depression in adults: recognition and Depression in adults: recognition and management management (CG90)" (PDF). NICE. 2009-10-28. เก็บจากแหล่งเดิมเมื่อ 2015-11-03. สืบค้นเมื่อ 2016-09-01.

nih.gov

pubmed.ncbi.nlm.nih.gov

Linde, K; Kriston, L; Rücker, G; Jamila, S; Schumann, I; Meissner, K; Sigterman, K; Schneider, A (Feb 2015). "Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis". Ann Fam Med. 13 (1): 69–79. doi:10.1370/afm.1687. PMC 4291268. PMID 25583895. In network meta-analysis, tricyclic and tetracyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), a serotonin-noradrenaline reuptake inhibitor (SNRI; venlafaxine), a low-dose serotonin antagonist and reuptake inhibitor (SARI; trazodone) and hypericum extracts were found to be significantly superior to placebo, with estimated odds ratios between 1.69 and 2.03. There were no statistically significant differences between these drug classes. Reversible inhibitors of monoaminoxidase A (rMAO-As) and hypericum extracts were associated with significantly fewer dropouts because of adverse effects compared with TCAs, SSRIs, the SNRI, a noradrenaline reuptake inhibitor (NRI), and noradrenergic and specific serotonergic antidepressant agents (NaSSAs). ... TCAs and SSRIs have the most solid evidence base. Further agents (hypericum, rMAO-As, SNRI, NRI, NaSSAs, SARI) showed some positive results, but limitations of the currently available evidence makes a clear recommendation on their place in clinical practice difficult.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Linde, K; Berner, MM; Kriston, L (2008). "St John's wort for major depression". Cochrane Database Syst Rev (4): CD000448. doi:10.1002/14651858.CD000448.pub3. PMID 18843608.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Hamilton, M (1960). "A rating scale for depression". J. Neurol. Neurosurg. Psychiatr. 23: 56–62. doi:10.1136/jnnp.23.1.56. PMC 495331. PMID 14399272.
Kirsch, I; Deacon, BJ; Huedo-Medina, TB; Scoboria, A; Moore, TJ; Johnson, BT (2008). "Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration". PLoS Medicine. 5 (2): e45. doi:10.1371/journal.pmed.0050045. PMC 2253608. PMID 18303940.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Fournier, JC; DeRubeis, RJ; Hollon, SD และคณะ (Jan 2010). "Antidepressant drug effects and depression severity: a patient-level meta-analysis". JAMA. 303 (1): 47–53. doi:10.1001/jama.2009.1943. PMC 3712503. PMID 20051569.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Borges, S; Chen, YF; Laughren, TP; Temple, R; Patel, HD; David, PA; Mathis, M; Unger, E; Yang, P; Khin, NA (2014). "Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration". J Clin Psychiatry. 75 (3): 205–14. doi:10.4088/JCP.13r08722. PMID 24717376.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Leucht, C; Huhn, M; Leucht, S (2012). Leucht, C (บ.ก.). "Amitriptyline versus placebo for major depressive disorder". Cochrane Database of Systematic Reviews. 12: CD009138. doi:10.1002/14651858.CD009138.pub2. PMID 23235671.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Zhou, X; Ravindran, AV; Qin, B; Del Giovane, C; Li, Q; Bauer, M; Liu, Y; Fang, Y; da Silva, T; Zhang, Y; Fang, L; Wang, X; Xie, P (Apr 2015). "Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis". J Clin Psychiatry. 76 (4): e487-98. doi:10.4088/JCP.14r09204. PMID 25919841. Quetiapine and aripiprazole appear to be the most robust evidence-based options for augmentation therapy in patients with treatment-resistant depression{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Walsh, BT; Seidman, SN; Sysko, R; Gould, M (2002). "Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing". JAMA. 287 (14): 1840–7. doi:10.1001/jama.287.14.1840. PMID 11939870.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Freeman, MP; Mischoulon, D; Tedeschini, E; Goodness, T; Cohen, LS; Fava, M; Papakostas, GI (2010). "Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants". J Clin Psychiatry. 71 (6): 682–8. doi:10.4088/JCP.10r05976blu. PMID 20573327.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Lee, K; Bacchetti, P; Sim, I (2008). Clarke, Mike (บ.ก.). "Publication of Clinical Trials Supporting Successful New Drug Applications: A Literature Analysis". PLoS Medicine. 5 (9): e191. doi:10.1371/journal.pmed.0050191. PMC 2553819. PMID 18816163.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Whittington, CJ; Kendall, T; Fonagy, P; Cottrell, D; Cotgrove, A; Boddington, E (2004). "Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data". The Lancet. 363 (9418): 1341–5. doi:10.1016/S0140-6736(04)16043-1. PMID 15110490.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Ebrahim, Shanil (2015). "Meta-analyses with industry involvement are massively published and report no caveats for antidepressants". Journal of Clinical Epidemology. doi:10.1016/j.jclinepi.2015.08.021. PMID 26399904.
Gibbons, RD; Hur, K; Brown, CH; Davis, JM; Mann, JJ (June 2012). "Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine". Archives of General Psychiatry. 69 (6): 572–9. doi:10.1001/archgenpsychiatry.2011.2044. PMC 3371295. PMID 22393205.
Taylor, MJ; Freemantle, N; Geddes, JR; Bhagwagar, Z (2006). "Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action: Systematic Review and Meta-analysis". Archives of General Psychiatry. 63 (11): 1217–23. doi:10.1001/archpsyc.63.11.1217. PMC 2211759. PMID 17088502.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Fava, M; Rush, AJ; Wisniewski, SR; Nierenberg, AA; Alpert, JE; McGrath, PJ; Thase, ME; Warden, D; Biggs, M; Luther, JF; Niederehe, G; Ritz, L; Trivedi, MH (2006). "A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report". The American Journal of Psychiatry. 163 (7): 1161–72. doi:10.1176/appi.ajp.163.7.1161. PMID 16816220.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Trivedi, MH; Fava, M; Wisniewski, SR; Thase, ME; Quitkin, F; Warden, D; Ritz, L; Nierenberg, AA; Lebowitz, BD; Biggs, MM; Luther, JF; Shores-Wilson, K; Rush, AJ (2006). "Medication Augmentation after the Failure of SSRIs for Depression". New England Journal of Medicine. 354 (12): 1243–52. doi:10.1056/NEJMoa052964. PMID 16554526.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Trivedi, MH; Rush, AJ; Wisniewski, SR; Nierenberg, AA; Warden, D; Ritz, L; Norquist, G; Howland, RH; Lebowitz, B; McGrath, PJ; Shores-Wilson, K; Biggs, MM; Balasubramani, GK; Fava, M (2006). "Evaluation of Outcomes with Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice". American Journal of Psychiatry. 163 (1): 28–40. doi:10.1176/appi.ajp.163.1.28. PMID 16390886.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Warden, D; Trivedi, MH; Wisniewski, SR; Davis, L; Nierenberg, AA; Gaynes, BN; Zisook, S; Hollon, SD; Balasubramani, GK; Howland, R; Fava, M; Stewart, JW; Rush, AJ (2007). "Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report". Am J Psychiatry. 164 (8): 1189–97. doi:10.1176/appi.ajp.2007.06071225. PMID 17671281.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Rush, AJ; Trivedi, MH; Wisniewski, SR; Stewart, JW; Nierenberg, AA; Thase, ME; Ritz, L; Biggs, MM; Warden, D; Luther, JF; Shores-Wilson, K; Niederehe, G; Fava, M (2006). "Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression". New England Journal of Medicine. 354 (12): 1231–42. doi:10.1056/NEJMoa052963. PMID 16554525.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Rush, AJ; Trivedi, MH; Wisniewski, SR และคณะ (Nov 2006). "Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report". Am J Psychiatry. 163 (11): 1905–17. doi:10.1176/appi.ajp.163.11.1905. PMID 17074942.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Warden, D; Rush, AJ; Trivedi, MH; Fava, M; Wisniewski, SR (2007). "The STAR*D Project results: A comprehensive review of findings". Current Psychiatry Reports. 9 (6): 449–59. doi:10.1007/s11920-007-0061-3. PMID 18221624.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Baghai, TC; Möller, HJ; Rupprecht, R (2006). "Recent Progress in Pharmacological and Non-Pharmacological Treatment Options of Major Depression". Current Pharmaceutical Design. 12 (4): 503–15. doi:10.2174/138161206775474422. PMID 16472142.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Ruhé, HG; Huyser, J; Swinkels, JA; Schene, AH (2006). "Switching Antidepressants After a First Selective Serotonin Reuptake Inhibitor in Major Depressive Disorder". The Journal of Clinical Psychiatry. 67 (12): 1836–55. doi:10.4088/JCP.v67n1203. PMID 17194261.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Tranter, R; O'Donovan, C; Chandarana, P; Kennedy, S (2002). "Prevalence and outcome of partial remission in depression". Journal of Psychiatry & Neuroscience. 27 (4): 241–7. PMC 161658. PMID 12174733.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Byrne, SE; Rothschild, AJ (1998). "Loss of Antidepressant Efficacy During Maintenance Therapy". The Journal of Clinical Psychiatry. 59 (6): 279–88. doi:10.4088/JCP.v59n0602. PMID 9671339.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Mischoulon, D; Nierenberg, AA; Kizilbash, L; Rosenbaum, JF; Fava, M (2000). "Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: A survey of clinicians". Canadian Journal of Psychiatry. 45 (5): 476–81. PMID 10900529.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Bschor, T; Baethge, C (2010). "No evidence for switching the antidepressant: Systematic review and meta-analysis of RCTs of a common therapeutic strategy". Acta Psychiatrica Scandinavica. 121 (3): 174–9. doi:10.1111/j.1600-0447.2009.01458.x. PMID 19703121.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
DeBattista, C; Lembke, A (2005). "Update on augmentation of antidepressant response in resistant depression". Current Psychiatry Reports. 7 (6): 435–40. doi:10.1007/s11920-005-0064-x. PMID 16318821.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Lam, RW; Wan, DD; Cohen, NL; Kennedy, SH (2002). "Combining Antidepressants for Treatment-Resistant Depression". The Journal of Clinical Psychiatry. 63 (8): 685–93. doi:10.4088/JCP.v63n0805. PMID 12197448.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Goss, AJ; Kaser, M; Costafreda, SG; Sahakian, BJ; Fu, CH (2013). "Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials". The Journal of Clinical Psychiatry. 74 (11): 1101–7. doi:10.4088/JCP.13r08560. PMID 24330897.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Geddes, JR; Carney, SM; Davies, C; Furukawa, TA; Kupfer, DJ; Frank, E; Goodwin, GM (2003). "Relapse prevention with antidepressant drug treatment in depressive disorders: A systematic review". The Lancet. 361 (9358): 653–61. doi:10.1016/S0140-6736(03)12599-8. PMID 12606176.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Targum, SD (Mar 2014). "Identification and treatment of antidepressant tachyphylaxis". Innov Clin Neurosci. 11 (3–4): 24–8. PMC 4008298. PMID 24800130.
Fava, GA; Offidani, E (2011). "The mechanisms of tolerance in antidepressant action". Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35 (7): 1593–602. doi:10.1016/j.pnpbp.2010.07.026. PMID 20728491.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Fava, GA; Park, SK; Sonino, N (2006). "Treatment of recurrent depression". Expert Review of Neurotherapeutics. 6 (11): 1735–40. doi:10.1586/14737175.6.11.1735. PMID 17144786.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Petersen, TJ (2006). "Enhancing the efficacy of antidepressants with psychotherapy". Journal of Psychopharmacology. 20 (3 suppl): 19–28. doi:10.1177/1359786806064314. PMID 16644768.
Ernst E; Rand JI; Barnes J; Stevinson C (1998). "Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.)". European Journal of Clinical Pharmacology. 54 (8): 589–94. doi:10.1007/s002280050519. PMID 9860144. Collectively, the data suggest that hypericum is well tolerated, with an incidence of adverse reactions similar to that of placebo.
Cipriani, A; Furukawa, TA; Salanti, G; Geddes, JR; Higgins, JP; Churchill, R; Watanabe, N; Nakagawa, A; Omori, IM; McGuire, H; Tansella, M; Barbui, C (2009). "Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis". Lancet. 373 (9665): 746–58. doi:10.1016/S0140-6736(09)60046-5. PMID 19185342.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
White, N; Litovitz, T; Clancy, C (2008). "Suicidal antidepressant overdoses: a comparative analysis by antidepressant type". J Med Toxicol. 4 (4): 238–50. doi:10.1007/BF03161207. PMC 3550116. PMID 19031375.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Bruijn, JA; Moleman, P; Mulder, PG; van den Broek, WW; van Hulst, AM; van der Mast, RC; van de Wetering, BJ (1996). "A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients". Psychopharmacology. 127 (3): 231–7. doi:10.1007/BF02246131. PMID 8912401.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Bruijn, JA; Moleman, P; Mulder, PG; van den Broek, WW (1999). "Depressed in-patients respond differently to imipramine and mirtazapine". Pharmacopsychiatry. 32 (3): 87–92. doi:10.1055/s-2007-979200. PMID 10463374.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
van Moffaert, M; de Wilde, J; Vereecken, A; Dierick, M; Evrard, JL; Wilmotte, J; Mendlewicz, J (Mar 1995). "Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression". Int Clin Psychopharmacol. 10 (1): 3–9. doi:10.1097/00004850-199503000-00001. PMID 7622801.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Goodwin, GM (2009). "Clinical studies on the efficacy of agomelatine on depressive symptoms". CNS Drugs. 23 Suppl 2: 35–9. doi:10.2165/11318650-000000000-00000. PMID 19708724.
Voican, CS; Corruble, E; Naveau, S; Perlemuter, G (Apr 2014). "Antidepressant-induced liver injury: a review for clinicians". The American Journal of Psychiatry. 171 (4): 404–15. doi:10.1176/appi.ajp.2013.13050709. PMID 24362450.
Fishback, JA; Robson, MJ; Xu, YT; Matsumoto, RR (2010). "Sigma receptors: potential targets for a new class of antidepressant drug". Pharmacol. Ther. 127 (3): 271–82. doi:10.1016/j.pharmthera.2010.04.003. PMC 3993947. PMID 20438757.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Kishimoto, A; Todani, A; Miura, J; Kitagaki, T; Hashimoto, K (2010). "The opposite effects of fluvoxamine and sertraline in the treatment of psychotic major depression: a case report". Ann Gen Psychiatry. 9: 23. doi:10.1186/1744-859X-9-23. PMC 2881105. PMID 20492642.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Borkowska, A; Pilaczyńska, E; Araszkiewicz, A; Rybakowski, J (2002). "[The effect of sertraline on cognitive functions in patients with obsessive-compulsive disorder]". Psychiatr. Pol. (ภาษาโปแลนด์). 36 (6 Suppl): 289–95. PMID 12647451.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Schmitt, JA; Ramaekers, JG; Kruizinga, MJ; van Boxtel, MP; Vuurman, EF; Riedel, WJ (2002). "Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man". J. Psychopharmacol. 16 (3): 207–14. doi:10.1177/026988110201600303. PMID 12236626.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Kapczinski, F; Lima, MS; Souza, JS; Schmitt, R (2003). Kapczinski, Flavio FK (บ.ก.). "Antidepressants for generalized anxiety disorder". Cochrane Database Syst Rev (2): CD003592. doi:10.1002/14651858.CD003592. PMID 12804478.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Arroll, B; Elley, CR; Fishman, T; Goodyear-Smith, FA; Kenealy, T; Blashki, G; Kerse, N; Macgillivray, S (2009). Arroll, Bruce (บ.ก.). "Antidepressants versus placebo for depression in primary care". The Cochrane Database of Systematic Reviews (3): CD007954. doi:10.1002/14651858.CD007954. PMID 19588448.{{cite journal}}: CS1 maint: multiple names: authors list (ลิงก์)
Fineberg, NA; Brown, A; Reghunandanan, S; Pampaloni, I (2012). "Evidence-based pharmacotherapy of obsessive-compulsive disorder". The International Journal of Neuropsychopharmacology. 15 (8): 1173–91. doi:10.1017/S1461145711001829. PMID 22226028.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Flament, MF; Bissada, H; Spettigue, W (Mar 2012). "Evidence-based pharmacotherapy of eating disorders". The International Journal of Neuropsychopharmacology. 15 (2): 189–207. doi:10.1017/S1461145711000381. PMID 21414249.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Häuser, W; Wolfe, F; Tölle, T; Uçeyler, N; Sommer, C (Apr 2012). "The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis". CNS Drugs. 26 (4): 297–307. doi:10.2165/11598970-000000000-00000. PMID 22452526.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Lunn, MP; Hughes, RA; Wiffen, PJ (2014). "Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia". Cochrane Database Syst Rev. 1: CD007115. doi:10.1002/14651858.CD007115.pub3. PMID 24385423.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
update Moore, RA; Derry, S; Aldington, D; Cole, P; Wiffen, PJ (2012). "Amitriptyline for neuropathic pain and fibromyalgia in adults". Cochrane Database Syst Rev. 12: CD008242. doi:10.1002/14651858.CD008242.pub2. PMID 23235657.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Birmes, P; Coppin, D; Schmitt, L; Lauque, D (2003). "Serotonin syndrome: a brief review". CMAJ. 168 (11): 1439–42. PMC 155963. PMID 12771076.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Boyer, EW; Shannon, M (2005). "The serotonin syndrome" (PDF). N. Engl. J. Med. 352 (11): 1112–20. doi:10.1056/NEJMra041867. PMID 15784664. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2013-06-18.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Mason, PJ; Morris, VA; Balcezak, TJ (2000). "Serotonin syndrome. Presentation of 2 cases and review of the literature". Medicine. 79 (4): 201–9. doi:10.1097/00005792-200007000-00001. PMID 10941349.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Sampson, E; Warner, JP (1999). "Serotonin syndrome: potentially fatal but difficult to recognize". Br J Gen Pract. 49 (448): 867–8. PMC 1313553. PMID 10818648.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Rao, Sathyanarayana TS; Yeragani, VK (2009). "Hypertensive crisis and cheese". Indian J Psychiatry. 51 (1): 65–6. doi:10.4103/0019-5545.44910. PMC 2738414. PMID 19742203.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Paykel, ES (1995). "Clinical efficacy of reversible and selective inhibitors of monoamine oxidase A in major depression". Acta Psychiatr Scand Suppl. 386: 22–7. doi:10.1111/j.1600-0447.1995.tb05920.x. PMID 7717091.
Malm, H (Dec 2012). "Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome". Therapeutic Drug Monitoring. 34 (6): 607–14. doi:10.1097/FTD.0b013e31826d07ea. PMID 23042258.
Rahimi, R; Nikfar, S; Abdollahi, M (2006). "Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials". Reproductive Toxicology (Elmsford, N.Y.). 22 (4): 571–575. doi:10.1016/j.reprotox.2006.03.019. PMID 16720091.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Nikfar, S; Rahimi, R; Hendoiee, N; Abdollahi, M (2012). "Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysis". Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 20 (1): 75. doi:10.1186/2008-2231-20-75. PMC 3556001. PMID 23351929.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Huang, H; Coleman, S; Bridge, JA; Yonkers, K; Katon, W (2014). "A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight". General Hospital Psychiatry. 36 (1): 13–8. doi:10.1016/j.genhosppsych.2013.08.002. PMC 3877723. PMID 24094568.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Einarson, TR; Kennedy, D; Einarson, A (2012). "Do findings differ across research design? The case of antidepressant use in pregnancy and malformations". Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Thérapeutique Des Populations Et De La Pharamcologie Clinique. 19 (2): e334-48. PMID 22946124.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Riggin, L; Frankel, Z; Moretti, M; Pupco, A; Koren, G (Apr 2013). "The fetal safety of fluoxetine: a systematic review and meta-analysis". Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC. 35 (4): 362–9. PMID 23660045.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Koren, G; Nordeng, HM (Feb 2013). "Selective serotonin reuptake inhibitors and malformations: case closed?". Seminars in Fetal & Neonatal Medicine. 18 (1): 19–22. doi:10.1016/j.siny.2012.10.004. PMID 23228547.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
di Scalea, T Lanza; Wisner, KL (2009). "Antidepressant Medication Use During Breastfeeding". Clinical Obstetrics and Gynecology. 52 (3): 483–97. doi:10.1097/GRF.0b013e3181b52bd6. PMC 2902256. PMID 19661763.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Goldberg, JF; Truman, CJ (2003). "Antidepressant-induced mania: An overview of current controversies". Bipolar Disorders. 5 (6): 407–20. doi:10.1046/j.1399-5618.2003.00067.x. PMID 14636364.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Benazzi, F (1997). "Antidepressant-associated hypomania in outpatient depression: a 203-case study in private practice". J Affect Disord. 46 (1): 73–7. doi:10.1016/S0165-0327(97)00082-7. PMID 9387089.
Stone, M; Laughren, T; Jones, ML; Levenson, M; Holland, PC; Hughes, A; Hammad, TA; Temple, R; Rochester, G (2009). "Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration". BMJ. 339: b2880. doi:10.1136/bmj.b2880. PMC 2725270. PMID 19671933.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Friedman, RA; Leon, AC (2007). "Expanding the black box - depression, antidepressants, and the risk of suicide". N. Engl. J. Med. 356 (23): 2343–6. doi:10.1056/NEJMp078015. PMID 17485726.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
update Cox, GR; Callahan, P; Churchill, R; Hunot, V; Merry, SN; Parker, AG; Hetrick, SE (2012). "Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents". Cochrane Database Syst Rev. 11: CD008324. doi:10.1002/14651858.CD008324.pub2. PMID 23152255.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Csoka, AB; Csoka, A; Bahrick, A; Mehtonen, OP (2008). "Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors". J Sex Med. 5 (1): 227–33. doi:10.1111/j.1743-6109.2007.00630.x. PMID 18173768.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Montejo, AL; Llorca, G; Izquierdo, JA; Rico-Villademoros, F (2001). "Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction". J Clin Psychiatry. 62 Suppl 3: 10–21. PMID 11229449.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Serretti, A; Chiesa, A (2009). "Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis". J Clin Psychopharmacol. 29 (3): 259–66. doi:10.1097/JCP.0b013e3181a5233f. PMID 19440080.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Chebili, S; Abaoub, A; Mezouane, B; JF, Le Goff (1998). "[Antidepressants and sexual stimulation: the correlation]". Encephale (ภาษาฝรั่งเศส). 24 (3): 180–4. PMID 9696909.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Keltner, NL; McAfee, KM; Taylor, CL (2009). "Biological Perspectives". Perspectives in Psychiatric Care. 38 (3): 111–6. doi:10.1111/j.1744-6163.2002.tb00665.x. PMID 12385082.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Ozmenler, NK; Karlidere, T; Bozkurt, A; Yetkin, S; Doruk, A; Sutcigil, L; Cansever, A; Uzun, O; Ozgen, F; Ozsahin, A (2008). "Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors". Hum Psychopharmacol. 23 (4): 321–6. doi:10.1002/hup.929. PMID 18278806.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Labbate, LA; Grimes, JB; Hines, A; Pollack, MH (Dec 1997). "Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction". Annals of Clinical Psychiatry. 9 (4): 241–5. doi:10.3109/10401239709147804. PMID 9511948.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Stimmel, GL; Dopheide, JA; Stahl, SM (1997). "Mirtazapine: An antidepressant with noradrenergic and specific serotonergic effects". Pharmacotherapy. 17 (1): 10–21. doi:10.1002/j.1875-9114.1997.tb03674.x. PMID 9017762.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Papakostas, GI (2008). "Tolerability of modern antidepressants". J Clin Psychiatry. 69 (Suppl E1): 8–13. PMID 18494538.
Li, Z; Maglione, M; Tu, W; Mojica, W; Arterburn, D; Shugarman, LR; Hilton, L; Suttorp, M; Solomon, V; Shekelle, PG; Morton, SC (Apr 2005). "Meta-analysis: pharmacologic treatment of obesity". Ann. Intern. Med. 142 (7): 532–46. doi:10.7326/0003-4819-142-7-200504050-00012. PMID 15809465.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Haddad, P. (2001). "Antidepressant discontinuation syndromes". Drug Saf. 24 (3): 183–97. doi:10.2165/00002018-200124030-00003. PMID 11347722.
Warner, CH; Bobo, W; Warner, C; Reid, S; Rachal, J (Aug 2006). "Antidepressant discontinuation syndrome". Am Fam Physician. 74 (3): 449–56. PMID 16913164.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Renoir, T (Apr 2013). "Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved". Front Pharmacol. 4: 45. doi:10.3389/fphar.2013.00045. PMC 3627130. PMID 23596418.
Haddad, PM; Dursun, SM (Jan 2008). "Neurological complications of psychiatric drugs: clinical features and management". Hum Psychopharmacol. 23 (Suppl 1): 15–26. doi:10.1002/hup.918. PMID 18098217.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Tamam, L.; Ozpoyraz, N. (2002, January-February). "Selective Serotonin Reuptake Inhibitor Discontinuation Syndrome: A Review". Advances in Therapy. 19 (1): 17–26. doi:10.1007/BF02850015. PMID 12008858. สืบค้นเมื่อ 2012-11-28. {{cite journal}}: ตรวจสอบค่าวันที่ใน: |date= (help)
Shelton, RC (2006). "The nature of the discontinuation syndrome associated with antidepressant drugs". J Clin Psychiatry. 67 (Suppl 4): 3–7. PMID 16683856.
Evans, EA; Sullivan, MA (Aug 2014). "Abuse and misuse of antidepressants". Subst Abuse Rehabil. 5: 107–20. doi:10.2147/SAR.S37917. PMID 25187753.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Nielsen, M; al., et (May 2012). "What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors". Addiction. 107 (5): 900–8. doi:10.1111/j.1360-0443.2011.03686.x. PMID 21992148.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Brady, K (May 2012). "Withdrawal or dependence: a matter of context. Comment on: What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors". Addiction. 107 (5): 910–1. doi:10.1111/j.1360-0443.2012.03862.x. PMID 22471576.
Lader, M (May 2012). "Dependence and withdrawal: comparison of the benzodiazepines and selective serotonin re-uptake inhibitors. Comment on: What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors". Addiction. 107 (5): 909–10. doi:10.1111/j.1360-0443.2011.03736.x. PMID 22471575.
Maes, M; Yirmyia, R; Noraberg, J; Brene, S; Hibbeln, J; Perini, G; Kubera, M; Bob, P; Lerer, B; Maj, M (Mar 2009). "The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression". Metabolic Brain Disease. 24 (1): 27–53. doi:10.1007/s11011-008-9118-1. PMID 19085093.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Sanacora, G; Treccani, G; Popoli, M (Jan 2012). "Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders". Neuropharmacology. 62 (1): 63–77. doi:10.1016/j.neuropharm.2011.07.036. PMC 3205453. PMID 21827775.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Menke, A; Klengel, T; Binder, EB (2012). "Epigenetics, depression and antidepressant treatment". Current Pharmaceutical Design. 18 (36): 5879–5889. doi:10.2174/138161212803523590. PMID 22681167.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Vialou, V; Feng, J; Robison, AJ; Nestler, EJ (Jan 2013). "Epigenetic mechanisms of depression and antidepressant action". Annual Review of Pharmacology and Toxicology. 53 (1): 59–87. doi:10.1146/annurev-pharmtox-010611-134540. PMID 23020296.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Fournier, JC; DeRubeis, RJ; Hollon, SD; Dimidjian, S; Amsterdam, JD; Shelton, RC; Fawcett, J (Jan 2010). "Antidepressant Drug Effects and Depression Severity". JAMA: The Journal of the American Medical Association. 303 (1): 47–53. doi:10.1001/jama.2009.1943. PMC 3712503. PMID 20051569.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Pies, R (Apr 2010). "Antidepressants Work, Sort of-Our System of Care Does Not". Journal of Clinical Psychopharmacology. 30 (2): 101–104. doi:10.1097/JCP.0b013e3181d52dea. PMID 20520282.
Cashman, JR; Ghirmai, S (2009). "Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression". Bioorganic & Medicinal Chemistry. 17 (19): 6890–7. doi:10.1016/j.bmc.2009.08.025. PMID 19740668.
Goldenberg, MM (Nov 2013). "Pharmaceutical approval update". P T. 38 (11): 705–7. PMC 3875258. PMID 24391391.
Hughes, ZA; Starr, KR; Langmead, CJ และคณะ (Mar 2005). "Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone". European Journal of Pharmacology. 510 (1–2): 49–57. doi:10.1016/j.ejphar.2005.01.018. PMID 15740724.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Wee, S; Woolverton, WL (Sep 2004). "Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine". Drug and Alcohol Dependence. 75 (3): 271–6. doi:10.1016/j.drugalcdep.2004.03.010. PMID 15283948.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Gasior, M; Bergman, J; Kallman, MJ; Paronis, CA (Apr 2005). "Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys". Neuropsychopharmacology. 30 (4): 758–64. doi:10.1038/sj.npp.1300593. PMID 15526000.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Rothman, RB; Baumann, MH; Dersch, CM และคณะ (Jan 2001). "Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin". Synapse. 39 (1): 32–41. doi:10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3. PMID 11071707.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Tatsumi, M; Groshan, K; Blakely, RD; Richelson, E (1997). "Pharmacological profile of antidepressants and related compounds at human monoamine transporters". Eur J Pharmacol. 340 (2–3): 249–258. doi:10.1016/S0014-2999(97)01393-9. PMID 9537821.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Gillman, PK (July 2007). "Tricyclic antidepressant pharmacology and therapeutic drug interactions updated". British Journal of Pharmacology. 151 (6): 737–48. doi:10.1038/sj.bjp.0707253. PMC 2014120. PMID 17471183.
Rénéric, JP; Lucki, I (Mar 1998). "Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test". Psychopharmacology. 136 (2): 190–7. doi:10.1007/s002130050555. PMID 9551776.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Walsh, B; Gladis, M; Roose, SP; Stewart, JW; Stetner, F; Glassman, AH (May 1988). "Phenelzine vs placebo in 50 patients with bulimia". Arch Gen Psychiatry. 45 (5): 471–5. doi:10.1001/archpsyc.1988.01800290091011. PMID 3282482.
Liebowitz, MR; Hollander, E; Schneier, F; Campeas, R; Welkowitz, L; Hatterer, J; Fallon, B (1990). "Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders". Acta Psychiatr Scand Suppl. 360: 29–34. doi:10.1111/j.1600-0447.1990.tb05321.x. PMID 2248064.
Bauer, M; Dopfmer, S (1999). "Lithium augmentation in treatment-resistant depression: Meta-analysis of placebo-controlled studies". Journal of Clinical Psychopharmacology. 19 (5): 427–34. doi:10.1097/00004714-199910000-00006. PMID 10505584.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Guzzetta, F; Tondo, L; Centorrino, F; Baldessarini, RJ (Mar 2007). "Lithium treatment reduces suicide risk in recurrent major depressive disorder". J Clin Psychiatry. 68 (3): 380–83. doi:10.4088/JCP.v68n0304. PMID 17388706.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Nierenberg, AA; Fava, M; Trivedi, MH; Wisniewski, SR; Thase, ME; McGrath, PJ; Alpert, JE; Warden, D; Luther, JF; Niederehe, G; Lebowitz, B; Shores-Wilson, K; Rush, AJ (2006). "A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: A STAR*D report". American Journal of Psychiatry. 163 (9): 1519–30. doi:10.1176/appi.ajp.163.9.1519. PMID 16946176.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Kraus, MF; Burch, EA (1992). "Methylphenidate hydrochloride as an antidepressant: controversy, case studies, and review". South. Med. J. 85 (10): 985–91. doi:10.1097/00007611-199210000-00012. PMID 1411740.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Orr, K; Taylor, D (2007). "Psychostimulants in the treatment of depression : a review of the evidence". CNS Drugs. 21 (3): 239–57. doi:10.2165/00023210-200721030-00004. PMID 17338594.
Weber, MM; Emrich, HM (1988). "Current and Historical Concepts of Opiate Treatment in Psychiatric Disorders". International Clinical Psychopharmacology. 3 (3): 255–66. doi:10.1097/00004850-198807000-00007. PMID 3153713.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Heal, DJ; Smith, SL; Gosden, J; Nutt, DJ (June 2013). "Amphetamine, past and present - a pharmacological and clinical perspective". J. Psychopharmacol. 27 (6): 479–96. doi:10.1177/0269881113482532. PMC 3666194. PMID 23539642.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Czygan, FC (2003). "Kulturgeschichte und Mystik des Johanniskrauts: Vom 2500 Jahre alten Apotropaikum zum aktuellen Antidepressivum" [From a 2500-year-old apotropic comes a current antidepressive. The cultural history and mistique of St. John's wort]. Pharmazie in unserer Zeit (ภาษาเยอรมัน). 32 (3): 184–90. doi:10.1002/pauz.200390062. PMID 12784538.
Selikoff, IJ; Robitzek, EH (1952). "Tuberculosis Chemotherapy with Hydrazine Derivatives of Isonicotinic Acid". CHEST Journal. 21 (4): 385–438. doi:10.1378/chest.21.4.385. PMID 14906149.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Robitzek, EH; Selikoff, IJ; Mamlok, E; Tendlau, A (1953). "Isoniazid and Its Isopropyl Derivative in the Therapy of Tuberculosis in Humans: Comparative Therapeutic and Toxicologic Properties". CHEST Journal. 23 (1): 1–15. doi:10.1378/chest.23.1.1. PMID 12998444.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
López-Muñoz, F; Alamo, C; Juckel, G; Assion, HJ (2007). "Half a Century of Antidepressant Drugs". Journal of Clinical Psychopharmacology. 27 (6): 555–9. doi:10.1097/jcp.0b013e3181bb617. PMID 18004120.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Kuhn, R (1958). "The treatment of depressive states with G 22355 (imipramine hydrochloride)". The American Journal of Psychiatry. 115 (5): 459–64. PMID 13583250.
Healy, D (1999). "The Three Faces of the Antidepressants: A Critical Commentary on the Clinical-Economic Context of Diagnosis". The Journal of Nervous & Mental Disease. 187 (3): 174–80. doi:10.1097/00005053-199903000-00007. PMID 10086474.
Pletscher, A (1991). "The discovery of antidepressants: A winding path". Experientia. 47 (1): 4–8. doi:10.1007/BF02041242. PMID 1999242.
Domino, EF (1999). "History of modern psychopharmacology: A personal view with an emphasis on antidepressants". Psychosomatic Medicine. 61 (5): 591–8. doi:10.1097/00006842-199909000-00002. PMID 10511010.
Wong, DT; Bymaster, FP; Horng, JS; Molloy, BB (1975). "A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3- (p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine". The Journal of Pharmacology and Experimental Therapeutics. 193 (3): 804–11. PMID 1151730. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-11-19. สืบค้นเมื่อ 2016-10-03.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Linde, K; Ramirez, G; Mulrow, CD; Pauls, A; Weidenhammer, W; Melchart, D (1996). "St John's wort for depression—an overview and meta-analysis of randomised clinical trials". BMJ. 313 (7052): 253–8. doi:10.1136/bmj.313.7052.253. PMC 2351679. PMID 8704532.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Müller, WE (2003). "Current St. John's wort research from mode of action to clinical efficacy". Pharmacological Research. 47 (2): 101–9. doi:10.1016/S1043-6618(02)00266-9. PMID 12543057.
Nathan, PJ (2001). "Hypericum perforatum (St John's Wort) : A non-selective reuptake inhibitor? A review of the recent advances in its pharmacology". Journal of Psychopharmacology. 15 (1): 47–54. doi:10.1177/026988110101500109. PMID 11277608.
Nentwig, G (2007). "Effects of pharmaceuticals on aquatic invertebrates. Part II: the antidepressant drug fluoxetine". Arch. Environ. Contam. Toxicol. 52 (2): 163–70. doi:10.1007/s00244-005-7190-7. PMID 17160491.
Zhou, Z; Zhen, J; Karpowich, NK; Goetz, RM; Law, CJ; Reith, ME; Wang, DN (2007). "LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake". Science. 317 (5843): 1390–3. doi:10.1126/science.1147614. PMC 3711652. PMID 17690258.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Brooks, BW; Chambliss, CK; Stanley, JK; Ramirez, A; Banks, KE; Johnson, RD; Lewis, RJ (2005). "Determination of select antidepressants in fish from an effluent-dominated stream". Environ. Toxicol. Chem. 24 (2): 464–9. doi:10.1897/04-081r.1. PMID 15720009.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Fent, K; Weston, AA; Caminada, D (2006). "Ecotoxicology of human pharmaceuticals". Aquat. Toxicol. 76 (2): 122–59. doi:10.1016/j.aquatox.2005.09.009. PMID 16257063.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Perreault, HA; Semsar, K; Godwin, J (2003). "Fluoxetine treatment decreases territorial aggression in a coral reef fish". Physiol. Behav. 79 (4–5): 719–24. doi:10.1016/S0031-9384(03)00211-7. PMID 12954414.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Huber, R; Smith, K; Delago, A; Isaksson, K; Kravitz, EA (1997). "Serotonin and aggressive motivation in crustaceans: altering the decision to retreat". Proc. Natl. Acad. Sci. U.S.A. 94 (11): 5939–42. doi:10.1073/pnas.94.11.5939. PMC 20885. PMID 9159179.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Di Poi, C; Darmaillacq, AS; Dickel, L; Boulouard, M; Bellanger, C (2013). "Effects of perinatal exposure to waterborne fluoxetine on memory processing in the cuttlefish Sepia officinalis". Aquat. Toxicol. 132–133: 84–91. doi:10.1016/j.aquatox.2013.02.004. PMID 23474317.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)

ncbi.nlm.nih.gov

Linde, K; Kriston, L; Rücker, G; Jamila, S; Schumann, I; Meissner, K; Sigterman, K; Schneider, A (Feb 2015). "Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis". Ann Fam Med. 13 (1): 69–79. doi:10.1370/afm.1687. PMC 4291268. PMID 25583895. In network meta-analysis, tricyclic and tetracyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), a serotonin-noradrenaline reuptake inhibitor (SNRI; venlafaxine), a low-dose serotonin antagonist and reuptake inhibitor (SARI; trazodone) and hypericum extracts were found to be significantly superior to placebo, with estimated odds ratios between 1.69 and 2.03. There were no statistically significant differences between these drug classes. Reversible inhibitors of monoaminoxidase A (rMAO-As) and hypericum extracts were associated with significantly fewer dropouts because of adverse effects compared with TCAs, SSRIs, the SNRI, a noradrenaline reuptake inhibitor (NRI), and noradrenergic and specific serotonergic antidepressant agents (NaSSAs). ... TCAs and SSRIs have the most solid evidence base. Further agents (hypericum, rMAO-As, SNRI, NRI, NaSSAs, SARI) showed some positive results, but limitations of the currently available evidence makes a clear recommendation on their place in clinical practice difficult.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Hamilton, M (1960). "A rating scale for depression". J. Neurol. Neurosurg. Psychiatr. 23: 56–62. doi:10.1136/jnnp.23.1.56. PMC 495331. PMID 14399272.
Kirsch, I; Deacon, BJ; Huedo-Medina, TB; Scoboria, A; Moore, TJ; Johnson, BT (2008). "Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration". PLoS Medicine. 5 (2): e45. doi:10.1371/journal.pmed.0050045. PMC 2253608. PMID 18303940.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Fournier, JC; DeRubeis, RJ; Hollon, SD และคณะ (Jan 2010). "Antidepressant drug effects and depression severity: a patient-level meta-analysis". JAMA. 303 (1): 47–53. doi:10.1001/jama.2009.1943. PMC 3712503. PMID 20051569.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Lee, K; Bacchetti, P; Sim, I (2008). Clarke, Mike (บ.ก.). "Publication of Clinical Trials Supporting Successful New Drug Applications: A Literature Analysis". PLoS Medicine. 5 (9): e191. doi:10.1371/journal.pmed.0050191. PMC 2553819. PMID 18816163.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Gibbons, RD; Hur, K; Brown, CH; Davis, JM; Mann, JJ (June 2012). "Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine". Archives of General Psychiatry. 69 (6): 572–9. doi:10.1001/archgenpsychiatry.2011.2044. PMC 3371295. PMID 22393205.
Taylor, MJ; Freemantle, N; Geddes, JR; Bhagwagar, Z (2006). "Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action: Systematic Review and Meta-analysis". Archives of General Psychiatry. 63 (11): 1217–23. doi:10.1001/archpsyc.63.11.1217. PMC 2211759. PMID 17088502.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Tranter, R; O'Donovan, C; Chandarana, P; Kennedy, S (2002). "Prevalence and outcome of partial remission in depression". Journal of Psychiatry & Neuroscience. 27 (4): 241–7. PMC 161658. PMID 12174733.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Targum, SD (Mar 2014). "Identification and treatment of antidepressant tachyphylaxis". Innov Clin Neurosci. 11 (3–4): 24–8. PMC 4008298. PMID 24800130.
White, N; Litovitz, T; Clancy, C (2008). "Suicidal antidepressant overdoses: a comparative analysis by antidepressant type". J Med Toxicol. 4 (4): 238–50. doi:10.1007/BF03161207. PMC 3550116. PMID 19031375.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Fishback, JA; Robson, MJ; Xu, YT; Matsumoto, RR (2010). "Sigma receptors: potential targets for a new class of antidepressant drug". Pharmacol. Ther. 127 (3): 271–82. doi:10.1016/j.pharmthera.2010.04.003. PMC 3993947. PMID 20438757.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Kishimoto, A; Todani, A; Miura, J; Kitagaki, T; Hashimoto, K (2010). "The opposite effects of fluvoxamine and sertraline in the treatment of psychotic major depression: a case report". Ann Gen Psychiatry. 9: 23. doi:10.1186/1744-859X-9-23. PMC 2881105. PMID 20492642.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
update Moore, RA; Derry, S; Aldington, D; Cole, P; Wiffen, PJ (2012). "Amitriptyline for neuropathic pain and fibromyalgia in adults". Cochrane Database Syst Rev. 12: CD008242. doi:10.1002/14651858.CD008242.pub2. PMID 23235657.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Birmes, P; Coppin, D; Schmitt, L; Lauque, D (2003). "Serotonin syndrome: a brief review". CMAJ. 168 (11): 1439–42. PMC 155963. PMID 12771076.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Sampson, E; Warner, JP (1999). "Serotonin syndrome: potentially fatal but difficult to recognize". Br J Gen Pract. 49 (448): 867–8. PMC 1313553. PMID 10818648.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Rao, Sathyanarayana TS; Yeragani, VK (2009). "Hypertensive crisis and cheese". Indian J Psychiatry. 51 (1): 65–6. doi:10.4103/0019-5545.44910. PMC 2738414. PMID 19742203.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Nikfar, S; Rahimi, R; Hendoiee, N; Abdollahi, M (2012). "Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysis". Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 20 (1): 75. doi:10.1186/2008-2231-20-75. PMC 3556001. PMID 23351929.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Huang, H; Coleman, S; Bridge, JA; Yonkers, K; Katon, W (2014). "A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight". General Hospital Psychiatry. 36 (1): 13–8. doi:10.1016/j.genhosppsych.2013.08.002. PMC 3877723. PMID 24094568.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
di Scalea, T Lanza; Wisner, KL (2009). "Antidepressant Medication Use During Breastfeeding". Clinical Obstetrics and Gynecology. 52 (3): 483–97. doi:10.1097/GRF.0b013e3181b52bd6. PMC 2902256. PMID 19661763.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Stone, M; Laughren, T; Jones, ML; Levenson, M; Holland, PC; Hughes, A; Hammad, TA; Temple, R; Rochester, G (2009). "Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration". BMJ. 339: b2880. doi:10.1136/bmj.b2880. PMC 2725270. PMID 19671933.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
update Cox, GR; Callahan, P; Churchill, R; Hunot, V; Merry, SN; Parker, AG; Hetrick, SE (2012). "Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents". Cochrane Database Syst Rev. 11: CD008324. doi:10.1002/14651858.CD008324.pub2. PMID 23152255.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Renoir, T (Apr 2013). "Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved". Front Pharmacol. 4: 45. doi:10.3389/fphar.2013.00045. PMC 3627130. PMID 23596418.
Gartlehner, G; Hansen, RA; Morgan, LC และคณะ (Dec 2011). Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review. Rockville, MD, USA: Agency for Healthcare Research and Quality.{{cite book}}: CS1 maint: uses authors parameter (ลิงก์)
Sanacora, G; Treccani, G; Popoli, M (Jan 2012). "Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders". Neuropharmacology. 62 (1): 63–77. doi:10.1016/j.neuropharm.2011.07.036. PMC 3205453. PMID 21827775.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Fournier, JC; DeRubeis, RJ; Hollon, SD; Dimidjian, S; Amsterdam, JD; Shelton, RC; Fawcett, J (Jan 2010). "Antidepressant Drug Effects and Depression Severity". JAMA: The Journal of the American Medical Association. 303 (1): 47–53. doi:10.1001/jama.2009.1943. PMC 3712503. PMID 20051569.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Goldenberg, MM (Nov 2013). "Pharmaceutical approval update". P T. 38 (11): 705–7. PMC 3875258. PMID 24391391.
Gillman, PK (July 2007). "Tricyclic antidepressant pharmacology and therapeutic drug interactions updated". British Journal of Pharmacology. 151 (6): 737–48. doi:10.1038/sj.bjp.0707253. PMC 2014120. PMID 17471183.
Heal, DJ; Smith, SL; Gosden, J; Nutt, DJ (June 2013). "Amphetamine, past and present - a pharmacological and clinical perspective". J. Psychopharmacol. 27 (6): 479–96. doi:10.1177/0269881113482532. PMC 3666194. PMID 23539642.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Linde, K; Ramirez, G; Mulrow, CD; Pauls, A; Weidenhammer, W; Melchart, D (1996). "St John's wort for depression—an overview and meta-analysis of randomised clinical trials". BMJ. 313 (7052): 253–8. doi:10.1136/bmj.313.7052.253. PMC 2351679. PMID 8704532.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Zhou, Z; Zhen, J; Karpowich, NK; Goetz, RM; Law, CJ; Reith, ME; Wang, DN (2007). "LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake". Science. 317 (5843): 1390–3. doi:10.1126/science.1147614. PMC 3711652. PMID 17690258.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Huber, R; Smith, K; Delago, A; Isaksson, K; Kravitz, EA (1997). "Serotonin and aggressive motivation in crustaceans: altering the decision to retreat". Proc. Natl. Acad. Sci. U.S.A. 94 (11): 5939–42. doi:10.1073/pnas.94.11.5939. PMC 20885. PMID 9159179.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)

nimh.nih.gov

"Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study". National Institute of Mental Health. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-03-05. สืบค้นเมื่อ 2012-11-28.

dailymed.nlm.nih.gov

"AMOXAPINE tablet [Watson Laboratories, Inc.]". DailyMed. Watson Laboratories, Inc. Aug 2010. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-11-02. สืบค้นเมื่อ 2013-10-30.

nlm.nih.gov

"Bupropion". MedlinePlus. 2016-02-15. สืบค้นเมื่อ 2016-03-10.

nytimes.com

Stutz, Bruce (2007-05-06). "Self-Nonmedication". New York Times. สืบค้นเมื่อ 2010-05-24.
Kramer, Peter (2011-09-07). "In Defense of Antidepressants". The New York Times. สืบค้นเมื่อ 2011-07-13.

pharmacist.com

"Vortioxetine: Atypical antidepressant". American Pharmacists Association. 2013. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2015-11-20. สืบค้นเมื่อ 2016-10-03.

psychiatrictimes.com

Cristancho, Mario. "Atypical Depression in the 21st Century: Diagnostic and Treatment Issues". Psychiatric Times. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-12-02. สืบค้นเมื่อ 2013-11-23.

psychiatrist.com

article.psychiatrist.com

Guzzetta, F; Tondo, L; Centorrino, F; Baldessarini, RJ (Mar 2007). "Lithium treatment reduces suicide risk in recurrent major depressive disorder". J Clin Psychiatry. 68 (3): 380–83. doi:10.4088/JCP.v68n0304. PMID 17388706.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)

psychiatryonline.org

"PsychiatryOnline | APA Practice Guidelines | Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Third Edition". คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2014-02-19. สืบค้นเมื่อ 2016-10-03.

psychosomaticmedicine.org

Domino, EF (1999). "History of modern psychopharmacology: A personal view with an emphasis on antidepressants". Psychosomatic Medicine. 61 (5): 591–8. doi:10.1097/00006842-199909000-00002. PMID 10511010.

qualitywatch.org.uk

Spence, Ruth. "Focus on: Antidepressant prescribing". QualityWatch. QualityWatch (Nuffield Trust/Health Foundation). คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2015-02-04. สืบค้นเมื่อ 2015-01-12.

rcpsych.org

bjp.rcpsych.org

Versiani, M; Nardi, AE; Mundim, FD; Alves, AB; Liebowitz, MR; Amrein, R (1992-09-01). "Pharmacotherapy of social phobia: A controlled study with moclobemide and phenelzine". BJP [Internet]. 161 (3): 353–60.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)

smith.edu

science.smith.edu

"Pharmacokinetics of selective serotonin reuptake inhibitors" (PDF). คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2014-05-23.

springer.com

Cusin, Cristina; Yang, Huaiyu; Yeung, Albert; Fava, Maurizio (2010). "Rating scales for depression" (PDF). ใน Baer, L; Blais, MA (บ.ก.). Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health. New York: Springer. pp. 7–36. ISBN 9781588299666. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2017-06-26. สืบค้นเมื่อ 2016-10-03.{{cite book}}: CS1 maint: multiple names: authors list (ลิงก์)

link.springer.com

Tamam, L.; Ozpoyraz, N. (2002, January-February). "Selective Serotonin Reuptake Inhibitor Discontinuation Syndrome: A Review". Advances in Therapy. 19 (1): 17–26. doi:10.1007/BF02850015. PMID 12008858. สืบค้นเมื่อ 2012-11-28. {{cite journal}}: ตรวจสอบค่าวันที่ใน: |date= (help)

thaidepression.com

แนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไป, "ALGORITHM 1 ASSESSMENT OF MAJOR DEPRESSIVE DISORDER", หน้า 15 คณะทำงานจัดทำแนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไปในในสถานบริการระดับปฐมภูมิและทุติยภูมิ (2010). "แนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไปในสถานบริการระดับปฐมภูมิและทุติยภูมิ (CPG-MDD-GP)" (PDF). กรมสุขภาพจิต กระทรวงสาธารณสุข. เก็บ (PDF)จากแหล่งเดิมเมื่อ 2012-05-26. สืบค้นเมื่อ 2016-10-03.{{cite web}}: CS1 maint: uses authors parameter (ลิงก์)
แนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไป, "Summary of Recommendations", หน้า 13-14 คณะทำงานจัดทำแนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไปในในสถานบริการระดับปฐมภูมิและทุติยภูมิ (2010). "แนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไปในสถานบริการระดับปฐมภูมิและทุติยภูมิ (CPG-MDD-GP)" (PDF). กรมสุขภาพจิต กระทรวงสาธารณสุข. เก็บ (PDF)จากแหล่งเดิมเมื่อ 2012-05-26. สืบค้นเมื่อ 2016-10-03.{{cite web}}: CS1 maint: uses authors parameter (ลิงก์)
แนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไป Appendix 11, หน้า 62-63 คณะทำงานจัดทำแนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไปในในสถานบริการระดับปฐมภูมิและทุติยภูมิ (2010). "แนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไปในสถานบริการระดับปฐมภูมิและทุติยภูมิ (CPG-MDD-GP)" (PDF). กรมสุขภาพจิต กระทรวงสาธารณสุข. เก็บ (PDF)จากแหล่งเดิมเมื่อ 2012-05-26. สืบค้นเมื่อ 2016-10-03.{{cite web}}: CS1 maint: uses authors parameter (ลิงก์)

time.com

"Psychic Energizer". Time. 1957-04-15. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-08-11. สืบค้นเมื่อ 2009-05-28.

toolserver.org

doi:10.1136/ard.2007.071522
This citation will be automatically completed in the next few minutes. You can jump the queue or expand by hand Full Article PDF (135 KB)

ucsd.edu

toxicology.ucsd.edu

Boyer, EW; Shannon, M (2005). "The serotonin syndrome" (PDF). N. Engl. J. Med. 352 (11): 1112–20. doi:10.1056/NEJMra041867. PMID 15784664. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2013-06-18.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)

uptodate.com

"Side effects of antidepressant medications". UpToDate. Wolters Kluwer Health. เก็บจากแหล่งเดิมเมื่อ 2013-11-02. สืบค้นเมื่อ 2013-10-24.

usatoday.com

"Study: Antidepressant barely better than placebo". USA Today. 2002-07-07. สืบค้นเมื่อ 2008-11-06.

web.archive.org

แนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไป, "ALGORITHM 1 ASSESSMENT OF MAJOR DEPRESSIVE DISORDER", หน้า 15 คณะทำงานจัดทำแนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไปในในสถานบริการระดับปฐมภูมิและทุติยภูมิ (2010). "แนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไปในสถานบริการระดับปฐมภูมิและทุติยภูมิ (CPG-MDD-GP)" (PDF). กรมสุขภาพจิต กระทรวงสาธารณสุข. เก็บ (PDF)จากแหล่งเดิมเมื่อ 2012-05-26. สืบค้นเมื่อ 2016-10-03.{{cite web}}: CS1 maint: uses authors parameter (ลิงก์)
แนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไป, "Summary of Recommendations", หน้า 13-14 คณะทำงานจัดทำแนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไปในในสถานบริการระดับปฐมภูมิและทุติยภูมิ (2010). "แนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไปในสถานบริการระดับปฐมภูมิและทุติยภูมิ (CPG-MDD-GP)" (PDF). กรมสุขภาพจิต กระทรวงสาธารณสุข. เก็บ (PDF)จากแหล่งเดิมเมื่อ 2012-05-26. สืบค้นเมื่อ 2016-10-03.{{cite web}}: CS1 maint: uses authors parameter (ลิงก์)
แนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไป Appendix 11, หน้า 62-63 คณะทำงานจัดทำแนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไปในในสถานบริการระดับปฐมภูมิและทุติยภูมิ (2010). "แนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไปในสถานบริการระดับปฐมภูมิและทุติยภูมิ (CPG-MDD-GP)" (PDF). กรมสุขภาพจิต กระทรวงสาธารณสุข. เก็บ (PDF)จากแหล่งเดิมเมื่อ 2012-05-26. สืบค้นเมื่อ 2016-10-03.{{cite web}}: CS1 maint: uses authors parameter (ลิงก์)
"Depression in Adults (update)" (PDF). National Collaborating Centre for Mental Health Commissioned by the National Institute for Health and Care Excellence. www.nice.org.uk. pp. 282–292. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2013-06-12. สืบค้นเมื่อ 2013-11-20.
Cusin, Cristina; Yang, Huaiyu; Yeung, Albert; Fava, Maurizio (2010). "Rating scales for depression" (PDF). ใน Baer, L; Blais, MA (บ.ก.). Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health. New York: Springer. pp. 7–36. ISBN 9781588299666. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2017-06-26. สืบค้นเมื่อ 2016-10-03.{{cite book}}: CS1 maint: multiple names: authors list (ลิงก์)
"Side effects of antidepressant medications". UpToDate. Wolters Kluwer Health. เก็บจากแหล่งเดิมเมื่อ 2013-11-02. สืบค้นเมื่อ 2013-10-24.
"AMOXAPINE tablet [Watson Laboratories, Inc.]". DailyMed. Watson Laboratories, Inc. Aug 2010. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-11-02. สืบค้นเมื่อ 2013-10-30.
"Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults" (PDF). NICE. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2012-10-21. สืบค้นเมื่อ 2013-02-20.
"Obsessive-compulsive disorder: Core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder" (PDF). Nov 2005. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2008-12-06. สืบค้นเมื่อ 2016-10-03.
"Medscape Log In". คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-04-13. สืบค้นเมื่อ 2016-10-03.
"National Guideline Clearinghouse | Practice guideline for the treatment of patients with eating disorders". คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-05-25. สืบค้นเมื่อ 2016-10-03.
Boyer, EW; Shannon, M (2005). "The serotonin syndrome" (PDF). N. Engl. J. Med. 352 (11): 1112–20. doi:10.1056/NEJMra041867. PMID 15784664. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2013-06-18.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
"FDA Advising of Risk of Birth Defects with Paxil" (Press release). U.S. Food and Drug Administration. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-12-03. สืบค้นเมื่อ 2012-11-29.
Sivagnanam, G (2012). "Antidepressants". Journal of Pharmacology and Pharmacotherapeutics. 3 (3): 287–8. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2018-07-01. สืบค้นเมื่อ 2016-10-03.
"Depression in adults: recognition and Depression in adults: recognition and management management (CG90)" (PDF). NICE. 2009-10-28. เก็บจากแหล่งเดิมเมื่อ 2015-11-03. สืบค้นเมื่อ 2016-09-01.
Healy, D; Aldred, G (2005). "Antidepressant drug use and the risk of suicide" (PDF). International Review of Psychiatry. 17: 163–172. doi:10.1080/09540260500071624. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2013-10-21. สืบค้นเมื่อ 2016-10-03.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
"mirtazapine (Rx) - Remeron, Remeron SolTab". Medscape. WebMD. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-10-29. สืบค้นเมื่อ 2013-11-19.
"Effexor Medicines Data Sheet". Wyeth Pharmaceuticals Inc. 2006. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2006-09-17. สืบค้นเมื่อ 2006-09-17.
"Vortioxetine: Atypical antidepressant". American Pharmacists Association. 2013. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2015-11-20. สืบค้นเมื่อ 2016-10-03.
Cristancho, Mario. "Atypical Depression in the 21st Century: Diagnostic and Treatment Issues". Psychiatric Times. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-12-02. สืบค้นเมื่อ 2013-11-23.
"Depressive Disorders". Merck Manual. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-12-05. สืบค้นเมื่อ 2012-11-30.
"Psychic Energizer". Time. 1957-04-15. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-08-11. สืบค้นเมื่อ 2009-05-28.
"Tranquilizers". Cumberland Mountain Community Services. www.cmcsb.com. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2012-09-16. สืบค้นเมื่อ 2013-11-20.^{[แหล่งอ้างอิงทางการแพทย์ที่ไม่น่าเชื่อถือ?]}
Wong, DT; Bymaster, FP; Horng, JS; Molloy, BB (1975). "A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3- (p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine". The Journal of Pharmacology and Experimental Therapeutics. 193 (3): 804–11. PMID 1151730. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-11-19. สืบค้นเมื่อ 2016-10-03.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)
Davis, Rowenna (2010-06-11). "Antidepressant Use Rises as Recession Feeds Wave of Worry". The Guardian. London. เก็บจากแหล่งเดิมเมื่อ 2010-06-15. สืบค้นเมื่อ 2010-07-01.
Spence, Ruth. "Focus on: Antidepressant prescribing". QualityWatch. QualityWatch (Nuffield Trust/Health Foundation). คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2015-02-04. สืบค้นเมื่อ 2015-01-12.
"Top 200 generic drugs by units in 2010" (PDF). คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2012-12-15.
"Top 200 brand drugs by units in 2010" (PDF). คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2012-04-22.
"GIPdatabank". Gipdatabank.nl. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2008-12-06. สืบค้นเมื่อ 2008-11-06.
"Pharmacokinetics of selective serotonin reuptake inhibitors" (PDF). คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2014-05-23.

webcitation.org

"Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study". National Institute of Mental Health. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2013-03-05. สืบค้นเมื่อ 2012-11-28.
Royal Pharmaceutical Society of Great Britain. MARTINDALE - The Complete Drug Reference. Pharmaceutical Press. เก็บจากแหล่งเดิมเมื่อ 2013-07-26. สืบค้นเมื่อ 2013-10-31.

websitetestlink.com

davidhealy.org.php53-23.dfw1-1.websitetestlink.com

Healy, D; Aldred, G (2005). "Antidepressant drug use and the risk of suicide" (PDF). International Review of Psychiatry. 17: 163–172. doi:10.1080/09540260500071624. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2013-10-21. สืบค้นเมื่อ 2016-10-03.{{cite journal}}: CS1 maint: uses authors parameter (ลิงก์)

who.int

apps.who.int

WHO Expert Committee on Drug Dependence (2003). "WHO Technical Report Series, No. 915 - Thirty-third Report". WHO.{{cite web}}: CS1 maint: uses authors parameter (ลิงก์)

wikipedia.org

th.wikipedia.org

doi:10.1136/ard.2007.071522
This citation will be automatically completed in the next few minutes. You can jump the queue or expand by hand Full Article PDF (135 KB)

wyeth.com

"Effexor Medicines Data Sheet". Wyeth Pharmaceuticals Inc. 2006. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2006-09-17. สืบค้นเมื่อ 2006-09-17.